National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

Found 2,686 cases where Vaccine is COVID19 and Symptom is Aborted pregnancy or Abortion or Abortion complete or Abortion early or Abortion incomplete or Abortion induced or Abortion late or Abortion missed or Abortion of ectopic pregnancy or Abortion spontaneous or Abortion spontaneous complete or Abortion spontaneous incomplete or Foetal cardiac arrest or Foetal death or Premature baby death or Premature delivery or Stillbirth

Government Disclaimer on use of this data



Case Details (Sorted by Onset Date)

This is page 24 out of 27

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next


VAERS ID: 1708906 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Female  
Location: California  
Vaccinated:2021-08-16
Onset:2021-08-17
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-09-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 030B21A / 1 RA / IM

Administered by: Work       Purchased by: ?
Symptoms: Abortion missed, Condition aggravated, Exposure during pregnancy, Muscle spasms, Pregnancy test positive, Subchorionic haemorrhage, Ultrasound scan abnormal, Ultrasound scan normal, Uterine dilation and curettage, Vaginal haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Dystonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Prenatal multivitamin 81mg aspirin Co-Q-10 methylfolate
Current Illness: n/a
Preexisting Conditions: migraine asthma
Allergies: n/a
Diagnostic Lab Data: Beta HCG tests on 8/20/21 and 8/22/21 indicated viable pregnancy. Sonogram on 8/20/21 and 8/30/21 indicated viable pregnancy. A sonogram on 9/7/21 noted missed abortion (miscarriage). D&C performed on 9/15/21.
CDC Split Type:

Write-up: Pregnancy confirmed on 8/9/21. EDD 4/18/22. Spotting and cramping were noted on 8/17/21. A sonogram on 8/20/21 visualized subchorionic hemorrhage and fetal pole. Sonogram on 8/30/21 - no hemorrhage noted. Normal pregnancy and gestational age were noted. Fetal pole and heartbeat observed. A sonogram on 9/7/21 noted the arrest of gestational growth and absence of heartbeat. Spotting and cramping were noted from 8/17/21 through 8/30/21. Arrest to fetal growth estimated at 9/1/21. History of prior miscarriage x 5. History of live term birth x 1.


VAERS ID: 1676022 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-16
Onset:2021-08-17
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-09-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FIMODERNATX, INC.MOD20212

Write-up: Miscarriage; Vaccine exposure during pregnancy; This case was received (Reference number: FI-FIMEA-20214070) on 27-Aug-2021 and was forwarded to Moderna on 27-Aug-2021. This regulatory authority retrospective pregnancy case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (Miscarriage) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 32-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. No Medical History information was reported. On 16-Aug-2021, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 17-Aug-2021, the patient experienced ABORTION SPONTANEOUS (Miscarriage) (seriousness criterion medically significant) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) (seriousness criterion medically significant). The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. At the time of the report, ABORTION SPONTANEOUS (Miscarriage) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had not resolved. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. No concomitant medications were provided. No treatment medications were provided. Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded; Sender''s Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded


VAERS ID: 1699931 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-16
Onset:2021-08-17
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Abortion spontaneous, Dizziness, Headache, Myalgia, Pain in extremity, Pyrexia, Vaccination site pain
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Vestibular disorders (broad), Termination of pregnancy and risk of abortion (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC202101139230

Write-up: This is a spontaneous report from a contactable other healthcare professional, via the regulatory authority (report number: 608977). A 32-year-old female patient received unknown dose number of BNT162B2 (Comirnaty, batch/lot# unknown), on Aug 16, 2021, single dose, for COVID-19 immunisation. The patient''s medical history and concomitant medications not reported. On Aug 17, 2021, (1 day after vaccination), patient experienced spontaneous abortion (medically significant), abdominal pain, dizziness, headache, injection site pain, myalgia, pain in extremity and pyrexia; with outcome of not recovered. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.


VAERS ID: 1701375 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-08-10
Onset:2021-08-17
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE7051 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Foetal death, Karyotype analysis, Maternal exposure timing unspecified
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-08-17
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LEVOTHYROX; UVEDOSE; SPASFON [PHLOROGLUCINOL]; PARACETAMOL; HYDROCORTISONE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Foetal macrosomia
Allergies:
Diagnostic Lab Data: Test Name: Cord blood sampling for foetal karyotype; Result Unstructured Data: Test Result:No results provided
CDC Split Type: FRPFIZER INC202101183106

Write-up: Maternal drug exposure during pregnancy; Foetal death in utero; This is a spontaneous report from a contactable physician downloaded . This is the second of two reports. The first report is a report downloaded from the Regulatory Authority-WEB, regulatory authority number FR-AFSSAPS-SE20212241. A fetus patient received bnt162b2 (COMIRNATY), dose 2 transplacental on 10Aug2021 (Batch/Lot Number: FE7051) as DOSE 2, SINGLE for covid-19 immunisation. Medical history and concomitant medications for the fetus were none. On 17Aug2021. the patient experienced foetal death in utero maternal drug exposure during pregnancy. with outcome of recovered with sequelae. This mother reported her last menstrual period was on 04Dec2020. The mother reported she became pregnant while taking bnt162b2. The mother was 36 Weeks pregnant at the onset of the event. On 17Aug2021 (Day 7 of the 2nd dose of COMIRNATY), the patient, at week 35 of amenorrhea + 5 days, consulted the Gynaecological Emergency Room for absence of active foetal movements for 3 days. On monitoring: no audible heart sounds. On ultrasound monitoring: No cardiac activity, no fetal movement, oligohydramnios, high anterior placenta, no image of haematoma. Labour induced on 20Aug2021. On 21Aug2021: A stillborn male child was delivered by vaginal delivery at 9:18 am. as due to deliver on 10Sep2021. The mother delivered the pregnancy on 21Aug2021 via vaginal delivery. The pregnancy resulted in still birth. The fetal outcome is intrauterine death. The patient underwent lab tests and procedures which included karyotype analysis: no results provided on unspecified date. The patient died on 17Aug2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-202101131236 same reporter, different patient( mother); Reported Cause(s) of Death: Foetal death in utero


VAERS ID: 1743313 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-22
Onset:2021-08-17
   Days after vaccination:26
Submitted: 0000-00-00
Entered: 2021-09-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC202101195527

Write-up: Miscarriage; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB NL-LRB-00681677. A 36-years-old female patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 22Jul2021 as dose 2, single for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient previously received bnt162b2 (COMIRNATY), dose 1 on 16Jun2021 for COVID-19 immunisation. The patient experienced miscarriage (medically significant) on 17Aug2021. The pregnancy resulted in spontaneous abortion. The first and second Covid vaccination took place before pregnancy. Miscarriage 26 days after start. The outcome of the event was unknown. Sender Comment: Since the nature of the reported reaction does imply seriousness according to one of the CIOMS critera, the reaction was considered as serious by the Netherlands Pharmacovigilance Centre Lareb. Reporter comment: BioNTech/Pfizer vaccine (Comirnaty) Past drug therapy BioNTech/Pfizer vaccine (Comirnaty): yes ADRs: I m not sure whether it s from the first or second vaccination. Date: 16Jun2021. Miscarriage. Additional information ADR: I was not yet pregnant at the time of vaccination and a connection with the vaccine cannot be established either. However, I still like to report it for the sake of possible statistics.COVID19. Previous COVID-19 infection: No No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reporter''s Comments: BioNTech/Pfizer vaccine (Comirnaty) Past drug therapy BioNTech/Pfizer vaccine (Comirnaty): yes ADRs: I m not sure whether it s from the first or second vaccination. Date: 16Jun2021. Miscarriage. Additional information ADR: I was not yet pregnant at the time of vaccination and a connection with the vaccine cannot be established either. However, I still like to report it for the sake of possible statistics.COVID19. Previous COVID-19 infection: No; Sender''s Comments: Linked Report(s) : NL-PFIZER INC-202101257100 the same patient/different dose


VAERS ID: 1763817 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-17
Onset:2021-08-17
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEMODERNATX, INC.MOD20213

Write-up: MISSFALL; MATERNAL EXPOSURE DURING PREGNANCY; This case was received via Regulatory Authority (Reference number: SE-MPA-2021-084716) on 30-Sep-2021 and was forwarded to Moderna on 01-Oct-2021. This regulatory authority retrospective pregnancy case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (MISSFALL) in a 32-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 17-Aug-2021, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 17-Aug-2021, after starting mRNA-1273 (Spikevax), the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (MATERNAL EXPOSURE DURING PREGNANCY). On 30-Aug-2021, the patient experienced ABORTION SPONTANEOUS (seriousness criterion medically significant). The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 17-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (MATERNAL EXPOSURE DURING PREGNANCY) had resolved. At the time of the report, ABORTION SPONTANEOUS outcome was unknown. No concomitant medication information were reported. No treatment medication information were reported. Batch no was in local language. Translation raised. This case concerns a 32 year-old female patient, with no relevant medical history reported who experienced the unexpected events of vaccine exposure during pregnancy and spontaneous abortion. The patient received the second dose of vaccine at 5 weeks of gestation. Spontaneous abortion occurred approximately 14 days after second dose of Spikevax. The rechallenge is not applicable. The benefit-risk relationship of Spikevax in not affected by this report. Event seriousness captured as per Regulatory Authority assessment in the Source Document.; Sender''s Comments: This case concerns a 32 year-old female patient, with no relevant medical history reported who experienced the unexpected events of vaccine exposure during pregnancy and spontaneous abortion. The patient received the second dose of vaccine at 5 weeks of gestation. Spontaneous abortion occurred approximately 14 days after second dose of Spikevax. The rechallenge is not applicable. The benefit-risk relationship of Spikevax in not affected by this report. Event seriousness captured as per Regulatory Authority assessment in the Source Document.


VAERS ID: 1847272 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-05
Onset:2021-08-17
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-11-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Gynaecological examination, Haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Obesity
Allergies:
Diagnostic Lab Data: Test Name: tests on the placenta; Result Unstructured Data: Test Result:do not reveal anything in particular
CDC Split Type: FRPFIZER INC202101462856

Write-up: patient had curettage operation which caused significant hemorrhage followed by 3 days of hospitalization with an iron infusion; Late miscarriage; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the Regulatory Agency (RA)-WEB, regulatory authority number FR-AFSSAPS-LY202112159. A 37-years-old female patient received first dose bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: Unknown) via intramuscular route of administration on 05Aug2021 as dose 1, single for COVID-19 immunization. Medical history included obesity, COVID-19 infection in January 2021 and gravidity and parity. The patient''s concomitant medications were not reported. Patient was pregnant at the time of vaccination. On 26May2021 patient start date of pregnancy. On 05Aug2021 patient took dose 1, while on 17Aug2021 estimated date of late miscarriage (at 15 weeks of amenorrhea by gynecologist) during emergency visit on 23Aug2021. On 27Aug2021 patient had curettage operation which caused significant hemorrhage followed by 3 days of hospitalization with an iron infusion. The patient underwent lab tests and procedures which included gynecological examination (placenta): Did not reveal anything in particular, operation: curettage operation. The pregnancy resulted in spontaneous abortion. The outcome of the event was recovered with sequel. No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.


VAERS ID: 1855915 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-17
Onset:2021-08-17
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE8087 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain lower, Abortion spontaneous, Asthenia, Vaginal haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101454945

Write-up: Cramp in lower abdomen; Spotting vaginal; Feelings of weakness; miscarriage; This is a spontaneous report from two contactable consumers downloaded from the regulatory authority number is GB-MHRA-WEBCOVID 202110201511340620-Z3AL4. Safety Report Unique Identifier is GB-MHRA-ADR 26098987. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: FE8087), via an unspecified route of administration on 17Aug2021 as dose 2, single for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient was pregnant at the time of vaccination. The patient had no medical issues. Patient has not had symptoms associated with COVID-19, not had a COVID-19 test. The patient experienced miscarriage and feelings of weakness, both on an unspecified date in 2021; cramp in lower abdomen and spotting vaginal, both on 17Aug2021. The mother was 4 weeks pregnant at the onset of the events. The pregnancy resulted in spontaneous abortion. The events were reported as serious per other medically important condition. The clinical course was reported as follows: 2nd dose of vaccine received at 4 weeks pregnant. Spotting and cramping on the same day as 2nd vaccine. Miscarriage at 8 weeks. Patient has not tested positive for COVID-19 since having the vaccine. Patient was not enrolled in clinical trial. This report did not relate to possible inflammation of the heart (myocarditis or pericarditis). The outcome of the events miscarriage and feelings of weakness was not recovered, while outcome of the remaining events was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.


VAERS ID: 1874754 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-17
Submitted: 0000-00-00
Entered: 2021-11-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH SCDD2 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101501378

Write-up: Miscarriage; This is a spontaneous report from a contactable consumer downloaded from the European Medicines Agency (EMA) EudraVigilance-WEB, regulatory authority number FR-AFSSAPS-LL20217096. A 36-year-old female patient received BNT162B2 (COMIRNATY), via intramuscular on an unspecified date (Lot Number: SCDD2) as dose 2, single for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient previously received COVID-19 vaccine MANUFACTURER UNKNOWN on unspecified date for COVID-19 immunisation. The patient experienced spontaneous miscarriage on 17Aug2021, following injection of the 2nd dose of vaccine (in the first trimester of pregnancy). The mother was 3 Trimester pregnant at the onset of the event. The pregnancy resulted in spontaneous abortion. The outcome of the event was not recovered. No follow-up attempts are possible. Information about lot/batch number cannot be obtain. No further information is expected.


VAERS ID: 1854064 (history)  
Form: Version 2.0  
Age: 29.0  
Sex: Female  
Location: Kansas  
Vaccinated:2021-08-17
Onset:2021-08-18
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-11-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Exposure during pregnancy, Foetal cardiac arrest, Foetal growth restriction, Ultrasound scan
SMQs:, Congenital and neonatal arrhythmias (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Prenatal vitamins
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Ultrasound confirmed no heartbeat. Had to have surgery to remove baby.
CDC Split Type:

Write-up: I was 6 weeks pregnant. And within 24 hours of getting the second covid dose my baby stopped growing and it?s heart stopped beating.


VAERS ID: 1660419 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-07-30
Onset:2021-08-18
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-09-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FF3319 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Inappropriate schedule of product administration
SMQs:, Termination of pregnancy and risk of abortion (narrow), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Polycystic ovarian syndrome
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101092914

Write-up: Inappropriate schedule of vaccine administered; Early miscarriage; This is a non-interventional study report from a contactable consumer received from the Regulatory authority. A 30-year-old patient of an unspecified gender received bnt162b2 (BNT162B2) via an unspecified route of administration on 30Jul2021 (Lot Number: Ff3319) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included polycystic ovaries from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. Patient had not symptoms associated with COVID-19. The patient had not a COVID-19 test. The patient previously took first dose of bnt162b2 (BNT162B2) via an unspecified route of administration on 03Jun2021 (Batch/Lot Number: Bt885) as DOSE 1, SINGLE for covid-19 immunisation. On18Aug2021, the patient experienced early miscarriage and on an unspecified date, inappropriate schedule of vaccine administered. Patient was not enrolled in clinical trial. The outcome of the event abortion spontaneous was recovering. No follow-up attempts are Possible. No further information is expected.


VAERS ID: 1701028 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-06-05
Onset:2021-08-18
   Days after vaccination:74
Submitted: 0000-00-00
Entered: 2021-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CAPFIZER INC202101138933

Write-up: This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received bnt162b2 (BNT162B2 reported as Covid19 Vaccine), dose 2 at vaccination age of 35-year-old via an unspecified route of administration in the left arm on 05Jun2021 14:45 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient received the first dose of bnt162b2 (BNT162B2 reported as Covid19 Vaccine) intramuscular in the left arm on 08May2021 at 03:00 PM for covid-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that they got pregnant approximately 3 weeks after second dose (Jun2021) and had a miscarriage 18Aug2021. She added that it was likely happened sooner but only found out on 18Aug2021. The patient has not been tested for COVID-19 since the vaccination. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment and has to take misoprostol. The outcome of the event was recovering. The lot number for BNT162b2 was not provided and will be requested during follow up.


VAERS ID: 1733696 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-13
Onset:2021-08-18
   Days after vaccination:36
Submitted: 0000-00-00
Entered: 2021-09-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEPFIZER INC202101195710

Write-up: Miscarriage; MATERNAL EXPOSURE DURING PREGNANCY; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the regulatory authority-WEB, regulatory authority number SE-MPA-2021-081644. This consumer or other non hcp reported information for both mother and fetus/baby. This is a maternal report. A 31-year-old female patient received first dose of bnt162b2 (COMIRNATY) via an unspecified route of administration on 13Jul2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient experienced maternal exposure during pregnancy on 2021 and miscarriage on 18Aug2021. The mother reported she became pregnant while taking bnt162b2. The mother was 11 Weeks pregnant at the onset of the event. The pregnancy resulted in spontaneous abortion. The doctor discovered at about week 10 of pregnancy that the embryo died at about week 5 of pregnancy. The regulatory authority assessed the report as serious while the reporter assesed it as non-serious. Outcome of the events was recovering. No follow-up attempts are possible. No further information expected. Information on batch/lot number cannot be obtained.


VAERS ID: 1780024 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-11
Onset:2021-08-18
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Pregnancy test
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FIASP
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210813; Test Name: Pregnancy test; Test Result: Positive ; Test Date: 20210817; Test Name: Pregnancy test; Test Result: Positive ; Test Date: 20210821; Test Name: Pregnancy test; Test Result: Negative
CDC Split Type: FIPFIZER INC202101278467

Write-up: Miscarriage; This is a spontaneous report from a contactable consumer (patient) downloaded from the Regulatory Agency (RA)-WEB. The regulatory authority number is FI-FIMEA-20215076. A 35-year-old, 4-weeks pregnant female patient received BNT162B2 (COMIRNATY; solution for injection; lot number was not reported), intramuscularly administered in the left arm on 11Aug2021 (at the age of 35-years-old, gestation period at exposure of 4 weeks) as dose 2, single for COVID-19 immunization. The patient''s medical history was not reported. Concomitant medication included insulin aspart (FIASP). On 18Aug2021, the patient experienced miscarriage. The patient''s pregnancy was detected by a pregnancy test on 13Aug2021 and confirmed by another test on 17Aug2021. Pregnancy test performed on 21Aug2021 was negative. The outcome of the event was recovered on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender''s Comments: Linked Report(s) : FI-PFIZER INC-202101278356 same reporter, patient, and drug; different dose and event


VAERS ID: 1675365 (history)  
Form: Version 2.0  
Age: 26.0  
Sex: Female  
Location: Washington  
Vaccinated:2020-12-26
Onset:2021-08-19
   Days after vaccination:236
Submitted: 0000-00-00
Entered: 2021-09-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Abortion spontaneous, COVID-19, Exposure during pregnancy, SARS-CoV-2 test positive, Ultrasound antenatal screen abnormal
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? Yes
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Augmentin
Diagnostic Lab Data: Covid test positive 08/14/2021; Miscarriage ultrasound 08/20/2021
CDC Split Type:

Write-up: I tested positive for Covid at 6 weeks pregnant from Ivf. I ended up having a miscarriage that same week.


VAERS ID: 1730451 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-02-19
Onset:2021-08-19
   Days after vaccination:181
Submitted: 0000-00-00
Entered: 2021-09-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / -

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, SARS-CoV-2 test
SMQs:, Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210514; Test Name: Nasal Swab/covid test; Test Result: Negative ; Test Date: 20210824; Test Name: Nasal Swab/covid test; Test Result: Negative
CDC Split Type: USPFIZER INC202101191979

Write-up: Miscarriage; This is a spontaneous report from a non-contactable consumer (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 19Feb2021 (Batch/Lot number was not reported) as dose 2, single (at the age of 38 years old) for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Jan2021 (Lot number: unknown, not available/provided to reporter at the time of report completion) administered in left arm as dose 1, single for COVID-19 immunization. No known allergies. No other vaccine in four weeks and no other medications in two weeks. The patient experienced miscarriage on 19Aug2021. The patient was hospitalized for miscarriage for 1 day. No COVID prior vaccination and was tested post vaccination. The patient underwent lab tests and procedures which included nasal swab/covid test: negative on 14May2021, Nasal Swab/covid test: negative on 24Aug2021. Therapeutic measures were taken as a result of miscarriage, treatment reported as "D and C". The outcome of the event was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1665953 (history)  
Form: Version 2.0  
Age: 28.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-04
Onset:2021-08-19
   Days after vaccination:46
Submitted: 0000-00-00
Entered: 2021-09-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No
Current Illness: No
Preexisting Conditions: No
Allergies: No
Diagnostic Lab Data: No. All the tets in relation with the pregnancy was more than good.
CDC Split Type:

Write-up: On 5th of July i have got the 1st doze Pfizer. After 2 weeks I understand that on 4th of July my pregnancy was happend already. But on 5th of July I didnt know that still. I didnt have any bad symptoms on the vaccination day, neither after the day. The baby and the vaccine started on the almost same day. 8weeks later the embrion was without heartbeat. I didnt know ehat to do about the second doze before to understand this awful new.. The doctors told me that I can take the second doze after the 5th month of the pregnancy. They gave me an unvalid sertificate and the pregnancy now is an awful memory...


VAERS ID: 1680013 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-17
Onset:2021-08-19
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-09-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anencephaly (pregnancy loss); Miscarriage of pregnancy (2 previous miscarriages); Pregnancy
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101105251

Write-up: Maternal exposure during pregnancy; Miscarriage; This is a spontaneous report from a contactable consumer or other non hcp received from the RA. The regulatory authority report number is GB-MHRA-EYC 00259032. Safety Report Unique Identifier GB-MHRA-ADR 25834695. A 34-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), dose 1 parenteral on 17Aug2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included abortion spontaneous from an unknown date and unknown if ongoing 2 previous miscarriages, anencephaly from an unknown date and unknown if ongoing pregnancy loss, pregnancy from an unknown date and unknown if ongoing. Concomitant medication(s) included folic acid taken for an unspecified indication, start and stop date were not reported. The patient had maternal exposure during pregnancy (hospitalization, medically significant) on an unspecified date. The patient experienced miscarriage (hospitalization, medically significant) on 19Aug2021. Patient had 3 previous pregnancy losses prior to this one. My unborn baby had no heart beat 2 days after having the covid vaccine. 8 weeks gestation. Up to that point, we were told the baby was developing normally. The baby had grown up to that point. The clinical outcome of event miscarriage was recovered with sequelae and other event outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1720603 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-12
Onset:2021-08-19
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-09-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Ultrasound foetal
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210819; Test Name: Ultrasound; Result Unstructured Data: Test Result:baby''s heart stopped beating
CDC Split Type: FRPFIZER INC202101166496

Write-up: Miscarriage; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB, regulatory authority number FR-AFSSAPS-LL20216048. This consumer reported information for both mother and fetus/baby. This is a maternal report. A 34-years-old female pregnant patient in her 1st trimester received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine (COMIRNATY), administered via intramuscular route in left arm on 12Aug2021 (Batch Number: FE7C1BSA) as single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient was not diagnosed with COVID before vaccination. On 19Aug2021 the patient experienced miscarriage (metrorrhagia presenting symptom), assessed as medically significant. The baby''s heart stopped beating, though, on her follow-up visit on 10Aug2021, his heart was beating. The mother was 6 weeks pregnant when she received the vaccine and at the onset of the event. The patient underwent ultrasound foetal on 19Aug2021 and interrupted the pregnancy "at 9 weeks" (as reported). The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-202101218927 Fetus case.


VAERS ID: 1720648 (history)  
Form: Version 2.0  
Age: 0.08  
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-08-12
Onset:2021-08-19
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-09-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE7C1BSA / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Foetal cardiac disorder, Foetal death
SMQs:, Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Aucun
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101218927

Write-up: The baby''s heart stopped beating; The baby''s heart stopped beating; This is a spontaneous report from a contactable consumer. This is the second of two reports. The first report is a report downloaded from the Regulatory Authority FR-AFSSAPS-LL20216048. This consumer reported information for both mother and fetus/baby. This is the fetus/baby report. A fetus patient of an unspecified gender received bnt162b2 (COMIRNATY), dose 1 transplacental on 12Aug2021 (Lot Number: FE7C1BSA) as dose 1, single for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The mother pregnant in her 1st trimester, vaccinated on 12Aug2021 at 6 weeks pregnant. On 19Aug2021 the parent had a miscarriage (metrorrhagia presenting symptom). The baby''s heart stopped beating. Though on her follow-up visit on 10Aug2021 the heart was beating. Ultrasound on 19Aug2021: interrupted pregnancy at 9 weeks. The baby died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-202101166496 Maternal/baby case; Reported Cause(s) of Death: The baby''s heart stopped beating; The baby''s heart stopped beating


VAERS ID: 1754634 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-04
Onset:2021-08-19
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-10-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FD4555 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Human chorionic gonadotropin
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210823; Test Name: Blood human chorionic gonadotropin; Result Unstructured Data: Test Result:2300; Comments: Unit not specfied; Test Date: 20210830; Test Name: Blood human chorionic gonadotropin; Result Unstructured Data: Test Result:32; Comments: Unit not specfied
CDC Split Type: DKPFIZER INC202101228793

Write-up: Spontaneous abortion week 7/8.; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the regulatory authority-WEB, regulatory authority number DK-DKMA-WBS-0087346. A 32-years-old female patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 04Aug2021 (Batch/Lot Number: FD4555; Expiration Date: 30Sep2021) and dose 1 via an unspecified route of administration on 07Jul2021 (Batch/Lot Number: FC1433; Expiration Date: 31Oct2021) both as single dose for covid-19 immunisation . The patient medical history and concomitant medications were not reported. The patient experienced spontaneous abortion week 7/8. (medically significant) on 19Aug2021 with outcome of not recovered. The patient discovered the pregnancy approx. 22 days after first injection. Received 2nd injections approx. at week 5 and Spontaneous abortion occurred at week 7/8 when vaccinated with Comirnaty (tozinameran). On 19Aug2021, 15 days after the second injection, the patient developed spontaneous abortion. The patient underwent lab tests and procedures which included human chorionic gonadotropin: 2300 on 23Aug2021 Unit not specfied , human chorionic gonadotropin: 32 on 30Aug2021 Unit not specfied. The ADR was by the regulatory authority assessed medically significant due to Spontaneous abortion being on the regulatory authority list. No treatment or medical procedures due to the ADR was reported. Causality: The patient states that she has no substance for the vaccine being the cause, as it is also well known that spontaneous abortion is a high risk the first 12 weeks of pregnancy, however she still reports the abortion as it may have relevance. No follow-up attempts possible. No further information expected.


VAERS ID: 1789772 (history)  
Form: Version 2.0  
Age: 41.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-19
Onset:2021-08-19
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Inappropriate schedule of product administration
SMQs:, Termination of pregnancy and risk of abortion (narrow), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Allergy to animals; Allergy to chemicals
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEPFIZER INC202101312559

Write-up: Miscarriage; dose 1 on 01Jul2021, Dose 2 on 19Aug2021; This is a spontaneous report from a contactable consumer reporting about herself. A 41-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration, administered in Arm Left on 19Aug2021 11:00 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation (age at vaccination: 41 years). Historical vaccine included bnt162b2 (COMIRNATY), dose 1, given on 01Jul2021 in left arm (age at vaccination: 41 years) for COVID-19 immunisation. Known allergies included formaldehyde and fur animals. The patient had not received any other vaccine within 4 weeks. Patient was pregnant at time of vaccination. Patient had no concomitant medications. The patient experienced miscarriage on 31Aug2021 07:00. Event required visit to HCP. The patient was 3 weeks pregnant at the onset of the event and was due to deliver on 30Apr2022. The pregnancy resulted in spontaneous abortion. Patient received no treatment for the event. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of the event miscarriage was recovered on an unspecified date. The lot number for bnt162b2, was not provided and will be requested during follow up.


VAERS ID: 1847307 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-08
Onset:2021-08-19
   Days after vaccination:42
Submitted: 0000-00-00
Entered: 2021-11-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain lower, Abortion spontaneous, Haemorrhage, SARS-CoV-2 test
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PARACETAMOL; DOLIPRANE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Assisted fertilization (conception with progesterone and estrogen treatment in 2012 and 2017); Pregnancy (two, children 2013 and 2018)
Allergies:
Diagnostic Lab Data: Test Date: 20210806; Test Name: Sars-cov-2 test; Test Result: Negative
CDC Split Type: FRPFIZER INC202101414708

Write-up: Miscarriage; lower abdominal pain; bleeding; This is a spontaneous report from a contactable consumer or other non HCP downloaded from the Regulatory Agency (RA)-WEB. The regulatory authority report number FR-AFSSAPS-TO20216958. A 42-year-old pregnant female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular, administered in Arm Left on 08Jul2021 (Batch/Lot Number: Unknown) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included pregnancy (2 children 2013 and 2018) and assisted fertilisation (conception with progesterone and estrogen treatment in 2012 and 2017). Concomitant medications included paracetamol taken for headache, start and stop date were not reported; paracetamol (DOLIPRANE) taken for headache, start and stop date were not reported. On 19Aug2021 she presented with abnormal bleeding and pain in the lower abdomen: spontaneous miscarriage in a context of unwanted pregnancy. The patient was hospitalized due to the events. The mother was 1 Trimester pregnant at the onset of the event. The pregnancy resulted in spontaneous abortion. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 06Aug2021. The patient recovered with sequel from the events on 19Aug2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1794044 (history)  
Form: Version 2.0  
Age: 26.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-08-02
Onset:2021-08-20
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-10-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / -

Administered by: Military       Purchased by: ?
Symptoms: Abortion spontaneous, Blood test, Exposure during pregnancy, Maternal exposure before pregnancy, Ultrasound scan
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None.
Preexisting Conditions: Asthma, Spongy Kidney Disease.
Allergies: Sulfa Drugs, Z-Pac, Aspirin
Diagnostic Lab Data: blood work, ultrasound, pelvic exam
CDC Split Type:

Write-up: Got first shot August 2nd, had a positive pregnancy test Augsut 16th, ended up in the hospital August 23rd and had a miscarriage.


VAERS ID: 1664324 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-20
Submitted: 0000-00-00
Entered: 2021-09-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Heavy menstrual bleeding, Pain, SARS-CoV-2 test
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CITALOPRAM
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anxiety; Lactation decreased; Miscarriage
Allergies:
Diagnostic Lab Data: Test Date: 20210105; Test Name: COVID-19 virus test; Test Result: Positive ; Comments: Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC202101093110

Write-up: miscarriage; Much more pain; heavier and earlier periods; This is a spontaneous report from a contactable consumer or other non hcp (patient) received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202108201449044190-3LUCV. Safety Report Unique Identifier GB-MHRA-ADR 25829806. A 29-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: not reported) via an unspecified route of administration on an unspecified date in 2021 as DOSE 2, SINGLE for covid-19 immunization. Historical vaccine included first dose of bnt162b2 as DOSE 1, SINGLE for COVID-19 immunisation. Patient had not had symptoms associated with COVID-19. Patient was not currently breastfeeding. Patient was not enrolled in clinical trial. Patient had not tested positive for COVID-19 since having the vaccine. The patient medical history included miscarriage, lactation decreased and anxiety from an unknown date and unknown if ongoing. The concomitant medication included citalopram taken for anxiety, start and stop date were not reported. It was reported that on an unspecified date, the patient experienced miscarriage, much more pain and heavier and earlier periods on 20Aug2021. Period came a week early. Much more pain which many of patient friends had also experienced since their second vaccine - heavier and earlier periods. Most unusual was a huge, globular clump of uterine lining came out within a few hours of cramps which patient had never experienced before in patient life. It was so huge patient thought patient was a miscarriage at first but looking closely it was uterus. On 05Jan2021, the patient underwent lab tests and procedures which included sars-cov-2 test was positive Yes (positive COVID-19 test). The outcome of event for miscarriage and much more pain was unknown and for event heavier and earlier periods was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1676227 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-11
Onset:2021-08-20
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-09-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FD8813 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy, Stillbirth
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? Yes
Birth Defect? Yes
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Live birth (3 previous normal live births); Pregnancy
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101138258

Write-up: Maternal exposure during pregnancy; Late miscarriage at 16 weeks and 4 days resulting in vagina birth to stillborn; Late miscarriage at 16 weeks and 4 days resulting in vagina birth to stillborn; This is a spontaneous report from a contactable consumer (Patient) received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-EYC 00259450 and Sender''s (Case) Safety Report Unique Identifier is GB-MHRA-ADR 25865180. This is a mother report. A 29-year-old pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Fd8813, Expiry date: not reported), via parenteral route on 11Aug2021 as dose number unknown, single for COVID-19 immunisation. The patient medical history included pregnancy, live birth (3 previous normal live births). The patient concomitant medications were not reported. On 20Aug2021, the patient experienced late miscarriage at 16 weeks and 4 days resulting in vagina birth to stillborn. The mother reported she became pregnant while taking BNT162B2. Maternal exposure during pregnancy considered an event. Case Narrative as reported: Late miscarriage at 16 weeks and 4 days resulting in vagina birth to stillborn. I did not want the vaccine as this vaccine was not investigated enough to prove it was safe in pregnant ladies. I was persuaded by health care professionals it was safe so I took it to keep my baby safe I have since been told there''s a potential link between vaccine and stillbirth but a health professional and that I have been one many in a influx of stillborn babies this week within the hospital and they what to know details of my Covid vaccine. My babies heartbeat stopped with no explanation. I had very frequent scans and checkup through the pregnancy and all was perfect with baby. Soon after vaccine my baby died and I was made to deliver. I have had 3 precious live births all with bleeding during pregnancy. All 3 were born safe and well no problems. This pregnancy seemed to be the easiest so far with few complications compared to my 3 others and with regular scans and check-up everyone was satisfied baby was fine and safe. 9 days following Pfizer jab my babies heartbeat stopped and precious scans suggested no reason for this autopsy is in process but the consultants and doctors are all pointing towards the jab being the problem looking at the pattern of stillborn observing the last 2 weeks following government advice on the news to get pregnant ladies vaccinated. The outcome of still birth was recovered on 28Aug2021. The outcome of late miscarriage was not recovered. Maternal exposure during pregnancy was Unknown. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1709492 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-17
Onset:2021-08-20
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-09-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE9174 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Amniocentesis, Foetal death, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Asperger''s syndrome
Preexisting Conditions: Medical History/Concurrent Conditions: Sclerosis multiple (type not further specified)
Allergies:
Diagnostic Lab Data: Test Name: Amniocentesis; Result Unstructured Data: Test Result:No results yet
CDC Split Type: DKPFIZER INC202101166002

Write-up: Intrauterine foetal death in week 36+3; Maternal exposure during pregnancy, third trimester; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, regulatory authority number DK-DKMA-WBS-0085989. A 37-years-old pregnant female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: FE9174; Expiration Date: 31Oct2021) intramuscular on 17Aug2021 as dose 2, single for COVID-19 immunization; diphtheria vaccine toxoid, tetanus vaccine toxoid (DITEBOOSTER) intramuscular from 09Aug2021 (Batch/Lot Number: KB0044D) to an unspecified date, at 1 DF for diphtheria immunisation. The patient previously took bnt162b2 (COMIRNATY, Batch/Lot Number: FD4555) on 23Jul2021 for COVID-19 immunization. Medical history included ongoing Asperger''s syndrome, multiple sclerosis (type not further specified). The patient''s concomitant medications were not reported. The patient experienced maternal exposure during pregnancy, third trimester and intrauterine foetal death in week 36+3 on 20Aug2021. The mother reported she became pregnant while taking bnt162b2, diphtheria vaccine toxoid, tetanus vaccine toxoid. The mother was 36 weeks pregnant at the onset of the event. On an unspecified date, the patient underwent lab tests and procedures which included amniocentesis: no results yet. Outcome of the event maternal exposure during pregnancy, third trimester was recovered while for the other event was not recovered. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1738647 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-17
Onset:2021-08-20
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-09-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FG6273 / 1 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, SARS-CoV-2 test
SMQs:, Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Covid-19 test; Test Result: Negative
CDC Split Type: FRPFIZER INC202101194517

Write-up: Abortion spontaneous; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB FR-AFSSAPS-TO20217445. A pregnant 25-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in Arm Right on 17Aug2021 (Batch/Lot Number: FG6273) as dose 1, single for covid-19 immunisation. The patient was due to deliver on 09Jan2022. Medical history and concomitant medications were not reported. The patient delivered the pregnancy on 20Aug2021. The pregnancy resulted in spontaneous abortion at 20 weeks gestation. The patient underwent lab tests and procedures which included SARS-COV-2 test which showed negative on an unspecified date. The outcome of the event was recovered with sequelae. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1666854 (history)  
Form: Version 2.0  
Age: 19.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-08-04
Onset:2021-08-21
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-09-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0183 / 2 - / -

Administered by: Private       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy, Human chorionic gonadotropin positive
SMQs:, Tumour markers (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Prenatal vitamin daily Iron 325 mg daily
Current Illness: None
Preexisting Conditions: None. Had a possible epileptic seizure at age 7, without further recurrence.
Allergies: Penicillin
Diagnostic Lab Data: Serum Beta HCGs 9/1/21: 13 8/25/21: 365 8/23/21 : 600
CDC Split Type:

Write-up: Spontaneous Abortion at approx. 6 weeks gestation.


VAERS ID: 1677485 (history)  
Form: Version 2.0  
Age: 29.0  
Sex: Female  
Location: California  
Vaccinated:2021-08-20
Onset:2021-08-21
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-09-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0185 / 1 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Abortion spontaneous, Headache, Nausea, Pain in extremity
SMQs:, Acute pancreatitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Termination of pregnancy and risk of abortion (narrow), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101093983

Write-up: Miscarriage; Left Arm pain; Nausea; Headache (HA); This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185), via an unspecified route of administration, administered in left arm on 20Aug2021 at 12:45 (at the age of 29-years-old) as dose 1, single for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered: Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history was not reported. The patient''s concomitant medications were not reported. On 21Aug2021 at 08:00 the patient experienced left arm pain, nausea and headache (HA). The vents were resolved with sequelae on an unspecified date in Aug2021. On 22Aug2021 the patient experienced miscarriage. The mother reported she became pregnant while taking bnt162b2. The mother was 5 weeks pregnant at the onset of the event. The mother was due to deliver on 18Apr2022. The outcome of event miscarriage was reported as unknown. The patient did not receive treatment for events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Based on the available information and a possible contributory role of the suspect product BNT162B2 to the development of event abortion spontaneous cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 1680558 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-21
Onset:2021-08-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy, SARS-CoV-2 test, Scan
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Folic acid supplementation; Lactation decreased; Miscarriage; Pregnancy (Patient no longer pregnant at the time of reporting.)
Allergies:
Diagnostic Lab Data: Test Date: 20210820; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Negative; Comments: No - Negative COVID-19 test; Test Name: scan; Result Unstructured Data: Test Result:no heart beat; Comments: Went to the scan and told there was no heart beat. Vaccine taken at 11+1 baby died at 11+3
CDC Split Type: GBPFIZER INC202101133106

Write-up: Miscarriage; Maternal exposure during pregnancy; This is a spontaneous report from a contactable consumer. This is a report received from the regulatory authority. Regulatory authority report number GB-MHRA-WEBCOVID-202108301639126920-YL2YN, Safety Report Unique Identifier GB-MHRA-ADR 25869929. This consumer or other non hcp reported information for both mother and fetus/baby. This is a maternal report. A 35-year-old pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: FC9001, Expiry date was not reported), via an unspecified route of administration on 21Aug2021 as single dose for COVID-19 immunization. The patient''s medical history included abortion spontaneous from an unknown date and unknown if ongoing, suppressed lactation from an unknown date and unknown if ongoing, pregnancy from an unknown date and unknown if ongoing (patient no longer pregnant at the time of reporting), Folic acid supplementation from an unknown date and unknown if ongoing. The patient''s concomitant medication(s) included folic acid was taken for Folic acid supplementation, start and stop date were not reported. Previously, the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number, Expiry date was not reported) via an unspecified route of administration on unknown date for COVID-19 immunization. The patient experienced maternal exposure during pregnancy on 21Aug2021, miscarriage on 23Aug2021. The mother reported she became pregnant while taking bnt162b2. The vaccine was taken at 11+1 weeks and baby died at 11+3 week. An autopsy was not performed. The patient went for a routine 12 weeks scan and told the baby died around the time of having the 2nd vaccine. Patient was not tested COVID-19 positive since having the vaccine. One previous miscarriage caused by detached placenta at 20 weeks. Patient was exposed to the medicine first-trimester. The event caused death, medically significant. The patient had 3 healthy pregnancies. The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 20Aug2021 No - Negative COVID-19 test, scan was no heartbeat (Went to the scan and told there was no heartbeat. Vaccine taken at 11+1 baby died at 11+3). The outcome of the event was maternal exposure during pregnancy was unknown, miscarriage was Fatal. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Miscarriage


VAERS ID: 1746684 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-21
Onset:2021-08-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE3380/V1328 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain upper, Abortion spontaneous, Back pain, Fatigue, Headache, Menstrual disorder, Menstruation delayed, Nausea, Thrombosis
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Termination of pregnancy and risk of abortion (narrow), Fertility disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101225383

Write-up: bleeding; miscarriage; Clot blood; headaches; nausea; fatigue; stomach cramps; back ache; Late period; This is a spontaneous report from a contactable consumer (patient) received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202109161109025300-YJNEF, Safety Report Unique Identifier GB-MHRA-ADR 25951831. A 27-year-old female patient (not pregnant, not currently breastfeeding; age at vaccination: 27-year-old) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot FE3380/V1328), via an unspecified route of administration on 21Aug2021 as dose 2, single for Covid-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient experienced bleeding, miscarriage on an unspecified date. She had late period on 21Aug2021. She had nausea, fatigue, stomach cramps, back ache and headache on 22Aug2021. On 06Sep2021, she experienced blood clot. The events were serious medically significant. The outcome of stomach cramps, clot blood was recovered on12Sep2021; for late period was recovered on 06Sep2021; for headache was unknown; for other events was not recovered. Clinical course of events: The patient was due on her period on 23Aug2021 but she didn''t actually come on until the 06Sep2021. When she did come on, she was heavily bleeding and was passing blood clots around 4-5 inches long. She had horrific stomach cramps and other period symptoms from the 22Aug2021 right through until around the 12Sep2021, including headaches, nausea, back ache and fatigue. She rang and spoke to her GP and Nurse Practitioner as she was concerned, she was having a miscarriage. They said it was possible, but they couldn''t be sure and if she was still bleeding more than a week, later to contact them back. No follow-up attempts are needed. No further information is expected.


VAERS ID: 1754838 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-19
Onset:2021-08-21
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-10-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FF2834 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101229241

Write-up: Pregnancy loss <20 weeks gestation; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB [FR-AFSSAPS-LY202110983]. A 29-year-old female patient, pregnant received the first dose of BNT162B2 (COMIRNATY; Lot Number: FF2834), intramuscular, administered in left arm on 19Aug2021 as single dose for COVID-19 immunisation. The patient''s medical history included asthma. The patient''s history of COVID-19 was unknown and it was unknown if the person has been tested for COVID-19. The patient''s concomitant medications were not reported. The patient experienced pregnancy loss <20 weeks gestation on 21Aug2021. The event resulted in emergency room visit. The patient''s date of last menstrual period was 14Jul2021. The patient reported she became pregnant while taking bnt162b2. The patient was 6 weeks pregnant at the onset of the event. The patient was due to deliver on 20Apr2022. The pregnancy resulted in spontaneous abortion. The outcome of the event was recovered on an unspecified date in 2021. The clinical course was reported as follows: 21Aug2021: visit to the emergency room given the metrorrhagia revealing a miscarriage at 6 weeks. The patient did not have an influenza-like illness / fever between the vaccination and the miscarriage. The reporter is in doubt as to the accountability for the vaccine and the event. Evolution: healing without complications. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1780213 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-10
Onset:2021-08-21
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE8235 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Abortion spontaneous, Back pain, Haemorrhage, Maternal exposure during pregnancy
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101291442

Write-up: Early miscarriage; maternal exposure during pregnancy, first trimester; bleedings; Pain over the back; Pain abdominal; This is a spontaneous report from a contactable other HCP downloaded from the Regulatory Agency (RA)-WEB FR-AFSSAPS-NT20214298. A 34-year-old female pregnant patient received bnt162b2 (COMIRNATY, formulation: Solution for injection, Lot number: FE8235), intramuscularly administered in arm left on 10Aug2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient''s last menstrual period on 09Jul2021. The patient did not had COVID-19 and not tested for COVID-19. On an unspecified date, the patient experienced maternal exposure during pregnancy, first trimester. The mother was 6 Weeks pregnant at the onset of the event. On 21Aug2021, the pregnant patient presents pain in the back and stomach. She was hospitalized for a miscarriage following bleedings. The mother reported she became pregnant while taking bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE). The mother was due to deliver on 15Apr2022. The pregnancy resulted in spontaneous abortion. The events spontaneous abortion, miscarriage following bleedings and maternal exposure during pregnancy, first trimester assessed as medically significant. On an unspecified date, the patient recovered with sequelae from early miscarriage and recovered from pain over the back and pain abdominal. The outcome of all other events was unknown. No follow-up attempts possible. No further information expected.


VAERS ID: 1786081 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-08-21
Onset:2021-08-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC5029 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Foetal death, Foetal growth restriction, Foetal hypokinesia, Head circumference, Head circumference abnormal, Maternal exposure during pregnancy, Physical examination, Ultrasound foetal
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Neonatal disorders (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-09-11
   Days after onset: 21
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210901; Test Name: Head circumference; Result Unstructured Data: Test Result:A little less than the previous scans, however no; Comments: A little less than the previous scans, however no indication for additional.; Test Date: 20210909; Test Name: Physical examination; Result Unstructured Data: Test Result:By midwife: Normal fetal movements and heartsound; Test Name: Ultrasound Foetal; Result Unstructured Data: Test Result:The fetus has previous been followed with Foetal u %; Comments: The fetus has previous been followed with Foetal ultrasound/weight scans due to slightly small foetal estimate; Test Date: 20210901; Test Name: Ultrasound Foetal; Test Result: -15.9 %
CDC Split Type: DKPFIZER INC202101323227

Write-up: slightly small foetal estimate; Foetus mortus GA 38+5; felt "less life" on 10Sep2021 and did not feel the baby at all 11Sep2021; Head circumference (01Sep2021): A little less than the previous scans; Maternal exposure during pregnancy, third trimester; This is a spontaneous report from a contactable physician. The first report is a report downloaded from the regulatory authority number DK-DKMA-WBS-0088235. This physician reported information for both mother and fetus. This is a fetus report. The 31 years old mother received BNT162b2 (COMIRNATY), second dose, intramuscularly on 21Aug2021 (Lot Number: FC5029; Expiration Date: 31Oct2021) as single dose for covid-19 immunisation. The patient''s mother medical history was previous has given birth to a large child GA 41+6 (4485 g), Pre-eclampsia (Mild pre-eclampsia in previous pregnancy). The patient''s mother concomitant medications were not reported. This fetus exposure under BNT162b2 via transplacental, third trimester. The patient experienced foetus mortus GA 38+5 on 11Sep2021. The mother felt "less life" on 10Sep2021 and did not feel the baby at all on 11Sep2021. Test results: Ultrasound Foetal: The fetus has previous been followed with Foetal ultrasound/weight scans due to slightly small foetal estimate. Ultrasound foetal (01Sep2021): -15.9%. Head circumference (01Sep2021): A little less than the previous scans, however no indication for additional. Physical examination (09Sep2021): By midwife: Normal fetal movements and heartsound. The patient died on 11Sep2021. It was not reported if an autopsy was performed. The outcome of the event Maternal exposure during pregnancy, third trimester, Dead fetus, felt "less life" was fatal, of the other events was unknown. The physician stated that cause of Dead fetus is unknown because the mother has not yet given birth to the foetus. It is unknown if the parents want an autopsy or genetic tests to be performed. Causality: The physician states that it difficult to assess if Comirnaty can have contributed to Dead fetus. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Linked Report(s) : DK-PFIZER INC-202101323012 same patient, different dose;DK-PFIZER INC-202101285247 mother case; Reported Cause(s) of Death: Maternal exposure during pregnancy, third trimester; Foetus mortus GA 38+5; felt "less life" on 10Sep2021 and did not feel the baby at all 11Sep2021


VAERS ID: 1663924 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: California  
Vaccinated:2021-06-01
Onset:2021-08-22
   Days after vaccination:82
Submitted: 0000-00-00
Entered: 2021-09-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0187 / 1 LA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0187 / 2 LA / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Blood test, Human chorionic gonadotropin, Pregnancy
SMQs:, Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Pre-Natal Vitamins
Current Illness: None
Preexisting Conditions: None
Allergies: Amoxicillin
Diagnostic Lab Data: Blood tests on 8/23/21 and 8/25/21 to measure HCG, confirmed miscarriage.
CDC Split Type:

Write-up: Got vaccinated in June (#1 6/5/21 and #2 6/26/21) Conceived in mid-July, miscarried in August when I was 8 weeks pregnant.


VAERS ID: 1668370 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-20
Onset:2021-08-22
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-09-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE3380 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? Yes
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Miscarriage; Pregnancy (Patient no longer pregnant at the time of reporting.); Pregnancy
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101111379

Write-up: Miscarriage; This is a spontaneous report from a contactable consumer (patient) received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202108251046184020-KSCHI. Safety Report Unique Identifier GB-MHRA-ADR 25846459. A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 20Aug2021 (Lot Number: FE3380) as single dose for COVID-19 immunisation. Medical history included abortion spontaneous, pregnancy, pregnancy (patient no longer pregnant at the time of reporting). Patient has not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient is not currently breastfeeding. The patient''s concomitant medications were not reported. The patient previously took folic acid. The patient experienced miscarriage (hospitalization, medically significant, congenital anomaly) on 22Aug2021. Clinical course: Patient found out she was around 6 weeks pregnant a couple of days after the vaccine, and then started to experience the symptoms of a miscarriage around 3 days later. She went to a&e yesterday and they confirmed it was a probable miscarriage and she has to return next week for a scan. She would not have had the vaccine if she had known she was pregnant. Patient has not tested positive for COVID-19 since having the vaccine. Patient is not enrolled in clinical trial. Patient had a miscarriage 3-4 days after. Patient did not take folic acid supplement during pregnancy. Patient was exposed to the medicine first-trimester (1-12 weeks). She was waiting a scan next Tuesday. The outcome of the event miscarriage was recovering. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1699980 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-22
Submitted: 0000-00-00
Entered: 2021-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC202101139642

Write-up: Abortion spontaneous; This is a spontaneous report from a contactable other health professional via the regulatory authority. Regulatory authority report number is 611530. This is a maternal report. A 33-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 22Aug2021, the patient experienced abortion spontaneous. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1732638 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-17
Onset:2021-08-22
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-09-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE9174 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Foetal death, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: MOVICOL [MACROGOL 3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE]; PANODIL; BETMIGA; COLECALCIFEROL; BAKLOFEN 2CARE4
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Constipation; Incontinence; Muscle cramps; Pain; Vitamin D deficiency
Allergies:
Diagnostic Lab Data:
CDC Split Type: DKPFIZER INC202101193361

Write-up: Dead fetus; Maternal exposure during pregnancy; This is a spontaneous report from contactable physicians downloaded from a regulatory authority-WEB, regulatory authority number DK-DKMA-WBS-0087096 and DK-DKMA-WBS-0087095. A 37-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 17Aug2021 (Lot Number: FE9174; Expiration Date: 30Oct2021) as DOSE 2, SINGLE; and via an unspecified route of administration on 23Jul2021 (Lot Number: FD4555) as DOSE 1, SINGLE for covid-19 immunisation; diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid, via an unspecified route of administration from 09Aug2021 (Lot Number: KB0044D) to 09Aug2021, at Dose number unknown, single for immunisation. Medical history included muscle cramps, incontinence, constipation, pain, and vitamin D deficiency. Concomitant medications included macrogol 3350, potassium chloride, sodium bicarbonate, sodium chloride dose 1 DF, 1x/day oral, taken for constipation from 20May2019; paracetamol Strength 500mg, dose 3000 mg, 1x/day, oral taken for pain from 02Sep2020; mirabegron Strength 50mg, dose 50 mg, 1x/day, taken for incontinence from 15Aug2017; colecalciferol (COLECALCIFEROL)Strength 35ug, dose 70 ug, 1x/day, oral taken for vitamin d deficiency from 20May2019; baclofen (BAKLOFEN 2CARE4) Strength 10mg, 20 mg, 1x/day, oral taken for muscle spasms from 06Oct2020. On 22Aug2021, the patient experienced dead fetus. The mother reported she became pregnant while taking bnt162b2, diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid. The events resulted in hospitalization. The outcome of the event dead fetus was not recovered. No follow-up attempts are possible. Information about batch number was obtained.


VAERS ID: 1733037 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-15
Onset:2021-08-22
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-09-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FD5613 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, SARS-CoV-2 test
SMQs:, Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Pregnancy (Patient no longer pregnant at the time of reporting)
Allergies:
Diagnostic Lab Data: Test Date: 20210302; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC202101205408

Write-up: Miscarriage of pregnancy; This is a spontaneous report from a contactable consumer. This is a report received from a regulatory authority. Regulatory authority report number is GB-MHRA-WEBCOVID-202109130920247110-HYYBE with Safety Report Unique Identifier GB-MHRA-ADR 25930795. A 32-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD5613) via an unspecified route of administration on 15Aug2021 as a single dose for COVID-19 immunisation. Medical history included pregnancy (patient no longer pregnant at the time of reporting) and suspect COVID-19 from 01Mar2021 to 05Mar2021. On 02Mar2021, the patient underwent a COVID-19 virus test and the result was positive and COVID-19 was stopped on 05Mar2021. The patient was not currently breastfeeding at the time of this report. The patient was not enrolled in a clinical trial. Concomitant medications included folic acid (MANUFACTURER UNKNOWN) taken for folic acid supplementation from an unknown date and unknown if ongoing. Patient was exposed to the medicine first-trimester (1-12 weeks). On 22Aug2021, 7 days after vaccination, the patient experienced miscarriage of pregnancy; all events reported as serious for being medically significant. It was unsure if the medicine had an adverse effect on any aspect of the pregnancy. The patient had not been tested positive for COVID-19 since having the vaccine. The clinical outcome of the event miscarriage of pregnancy was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.


VAERS ID: 1738394 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-16
Onset:2021-08-22
   Days after vaccination:37
Submitted: 0000-00-00
Entered: 2021-09-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE2707 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy, Myalgia, Vaccination site pain
SMQs:, Rhabdomyolysis/myopathy (broad), Eosinophilic pneumonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101193945

Write-up: muscle aches; slight pain in the injection site; Maternal Exposure During Pregnancy, first trimester; Early miscarriage; This is a spontaneous report from a contactable consumer (patient) downloaded from the regulatory authority-WEB. Regulatory authority number is FR-AFSSAPS-LY202110425. A 37-year-old female patient received bnt162b2 (COMIRNATY), intramuscular, arm left, on 16Jul2021 (Batch/Lot Number: FE2707, Expiry date not reported) as DOSE 1, SINGLE for COVID-19 immunization. Medical history and concomitant medications were not reported. The mother reported she was pregnant while taking bnt162b2. The mother was 10 weeks pregnant at the onset of the event. The mother was due to deliver on 19Mar2022. The patient experienced early miscarriage on 22Aug2021 with outcome of recovered with sequelae on an unspecified date, muscle aches on an unspecified date with outcome of unknown, slight pain in the injection site on an unspecified date with outcome of unknown, and maternal exposure during pregnancy, first trimester on an unspecified date with outcome of unknown. The event early miscarriage was assessed as serious, medically significant, while other events were non-serious. No follow up attempts are possible, no further information is expected.


VAERS ID: 1746277 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-07
Onset:2021-08-22
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-09-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE8244 / UNK LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood grouping, Foetal death, Foetal hypokinesia, Investigation, Magnetic resonance imaging, Rubella, Rubella in pregnancy, SARS-CoV-2 antibody test, Toxoplasmosis, Trisomy 21, Ultrasound foetal
SMQs:, Congenital, familial and genetic disorders (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow), Opportunistic infections (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Factor V Leiden mutation (Heterozygous); Non-smoker
Allergies:
Diagnostic Lab Data: Test Name: blood group; Result Unstructured Data: Test Result:AB+; Test Name: examination; Result Unstructured Data: Test Result:Unfavourable cervix; Test Name: T2-weighted imaging; Result Unstructured Data: Test Result:492g-79%; Comments: no SAE (Serious Adverse Event), no placental anomaly; Test Name: rubella; Test Result: Positive ; Test Date: 20210822; Test Name: COVID Polymerase Chain Reaction test; Test Result: Negative ; Test Name: toxoplasmosis test; Test Result: Negative ; Test Name: Trisomy 21 (T21) risk; Result Unstructured Data: Test Result:<1/10,000; Test Name: ultrasound; Result Unstructured Data: Test Result:No heart sounds on ultrasound, finding fetal death; Comments: No heart sounds on ultrasound, finding fetal death in utero. The fetus did not show any edema or major malformation; placenta devoid of any unusual areas. Normal amount of anechoic amniotic fluid.
CDC Split Type: FRPFIZER INC202101215949

Write-up: rubella: positive; Foetal death in utero; decrease in active fetal movements; This is a spontaneous report from a contactable pharmacist from the regulatory authority-WEB, regulatory authority number FR-AFSSAPS-LY202110428. A 28-year-old female patient received BNT162B2 (COMIRNATY), intramuscular, administered in arm left on 07Aug2021 (Lot Number: FE8244) as dose number unknown, single for COVID-19 vaccination at 26 weeks of pregnancy (as reported). Medical history included Heterozygous Factor V Leiden Mutation, no smoking; from an unknown date. There were no concomitant medications. There was no information on whether pregnancy was spontaneous or not; estimated pregnancy start date on 15Feb2021; pregnancy progressed without any complications. On 22Aug2021, decrease in active fetal movements at 28 weeks of pregnancy plus 1 day, discovered at 5:00 pm. At 11:00 pm: No heart sounds on ultrasound, finding fetal death in utero. The fetus did not show any edema or major malformation; placenta devoid of any unusual areas. Normal amount of anechoic amniotic fluid. Patient was afebrile and described no pain or discharge. No smoking, no medication, no intake of toxic substances, has not been hit, has been careful with her diet (the husband was a smoker and cannabis addict but smoked away from his wife). Unfavourable cervix upon examination on unspecified date, male sex, couple stunned by the announcement. On 22Aug2021, COVID Polymerase Chain Reaction test: negative. On 23Aug2021, administration of MIFEGYNE. On 25Aug2021, delivery by vaginal route; psychological care of the patient. No complications following delivery. On 27Aug2021, returned homeAdditional tests on unspecified date included blood group: ABpositive, toxoplasmosis test: negative, rubella: positive, Trisomy 21 (T21) risk: less than 1/10,000, T2-weighted imaging: 492g - 79%, no SAE (Serious Adverse Event), no placental anomaly. Therapeutic measures were taken as a result of foetal death in utero. The outcome of the events was resolved with sequel. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1807263 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-12
Onset:2021-08-22
   Days after vaccination:41
Submitted: 0000-00-00
Entered: 2021-10-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 214001 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Kronans Apotek Folsyra 400 ?g; Vegan vitamin supplement
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEMODERNATX, INC.MOD20213

Write-up: Missfall; Maternal exposure during pregnancy; This case was received (Reference number: SE-MPA-2021-086439) on 14-Oct-2021 and was forwarded to Moderna on 14-Oct-2021. This regulatory authority retrospective pregnancy case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (Missfall) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 31-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 214001) for COVID-19 vaccination. Concomitant products included Folic acid (Kronans Apotek Folsyra 400 ?g) and Vitamins (Vegan vitamin supplement) for an unknown indication. On 12-Jul-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. In 2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) (seriousness criterion medically significant). On 22-Aug-2021, the patient experienced ABORTION SPONTANEOUS (Missfall) (seriousness criterion medically significant). The delivery occurred on 22-Aug-2021, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 24-Aug-2021, ABORTION SPONTANEOUS (Missfall) had resolved. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. No treatment medication were provided Gestation period when reaction/event was observed in the fetus was 10 weeks. This case of maternal exposure during pregnancy concerns a 31-year-old female patient, with no relevant medical history, who experienced the serious unexpected events of ABORTION SPONTANEOUS. The event occurred approximately 1 month after the administration of the first dose of Spikevax vaccine. The rechallenge was not applicable since no information about the second dose was available. The benefit-risk relationship of Spikevax is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 14-Oct-2021: Translation received on 16-Oct-21 with no new information.; Sender''s Comments: This case of maternal exposure during pregnancy concerns a 31-year-old female patient, with no relevant medical history, who experienced the serious unexpected events of ABORTION SPONTANEOUS. The event occurred approximately 1 month after the administration of the first dose of Spikevax vaccine. The rechallenge was not applicable since no information about the second dose was available. The benefit-risk relationship of Spikevax is not affected by this report.


VAERS ID: 1819059 (history)  
Form: Version 2.0  
Age: 30.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-22
Onset:2021-08-22
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Blood test, Gynaecological examination, Inappropriate schedule of product administration, Maternal exposure during pregnancy, Smear test, Ultrasound scan
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Pregnancy (The first pregnancy had a birth in May2018.)
Allergies:
Diagnostic Lab Data: Test Name: blood test; Result Unstructured Data: Test Result:normal; Test Name: gynecological assessment; Result Unstructured Data: Test Result:Unknown result; Test Name: smear; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210830; Test Name: ultrasound; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210909; Test Name: ultrasound; Result Unstructured Data: Test Result:the pregnancy was progressive, the pregnancy is da; Comments: the pregnancy was progressive, the pregnancy is dated at 5SA, while it is according to the patient''s cycle at 6.5SA; Test Date: 20210928; Test Name: ultrasound; Result Unstructured Data: Test Result:the death in utero of the embryo (9SA +2). Embryo; Comments: the death in utero of the embryo (9SA +2). Embryo death in utero is estimated at 7NW + 4.
CDC Split Type: FRPFIZER INC202101350113

Write-up: Pregnancy loss <20 weeks gestation; Pregnancy loss <20 weeks gestation; first dose then a second dose of COMIRNATY vaccine on 08Aug2021 and 22Aug2021 respectively; This is a spontaneous report from a contactable consumer downloaded from a regulatory authority-WEB, regulatory authority number FR-AFSSAPS-AN20213872. A 30-year-old female patient received bnt162b2 (COMIRNATY, Batch/Lot Number: Unknown), dose 2 intramuscular on 22Aug2021 (at the age of 30years) as dose 2, single for Covid-19 immunization. Medical history included pregnancy (The first pregnancy had a birth in May2018). The patient''s concomitant medications were not reported. The patient was vaccinated with a first dose then a second dose of COMIRNATY vaccine on 08Aug2021 and 22Aug2021 respectively. Date of last menstruation estimated at 24Jul2021. The patient experienced pregnancy loss <20 weeks gestation on 28Sep2021. The mother reported she became pregnant while taking bnt162b2. The mother was 9 Weeks pregnant at the onset of the event. The mother was due to deliver on 30Apr2022. The mother delivered the pregnancy on 28Sep2021. The pregnancy resulted in spontaneous abortion. The fetal outcome is intrauterine death. It was reported that the patient had a spontaneous miscarriage 37 days after a second dose of Comirnaty vaccine. The patient presented bleeding from a vaginal lesion early in her pregnancy. On 30Aug2021, the gynecologist performed an ultrasound (unknown result). On 09Sep2021, new ultrasound to verify that the pregnancy was progressive, the pregnancy is dated at 5SA, while it is according to the patient''s cycle at 6.5SA. On 28Sep21, new ultrasound which reveals the death in utero of the embryo (9SA +2). Embryo death in utero is estimated at 7NW + 4. The patient describes having no gynecological history. This was her second pregnancy. Before the planned pregnancy, the patient had undergone a gynecological assessment as well as a smear and a normal blood test; all on an unspecified date. Covid-19 test: PCR / serology: not performed. TREATMENT AND EVOLUTION: Expulsion of the embryo on 28Sep2021. The outcome of event Pregnancy loss <20 weeks gestation was not recovered. The lot number for BNT162B2was not provided and will be requested during follow up.


VAERS ID: 1820024 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-21
Onset:2021-08-22
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-10-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Ageusia, Chest discomfort, Headache, Influenza like illness
SMQs:, Anaphylactic reaction (broad), Taste and smell disorders (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NZPFIZER INC202101362646

Write-up: Abortion spontaneous; Ageusia; chest discomfort; headache; Influenza like illness; This is a spontaneous report from a contactable consumer from the Medsafe. Regulatory authority report number is AEFI-A-026920. A 31-year-old female pregnant patient received the first dose of bnt162b2 (COMIRNATY, Batch/Lot number was not reported), via an unspecified route of administration on 21Aug2021 (unknown age at time of vaccination) as single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced abortion spontaneous, ageusia, chest discomfort, headache, and influenza like illness on 22Aug2021 08:30 (Date time of first occurrence was 22Aug2021 8:30). Seriousness was reported as congenital effect. Reporter''s description of AEFI: loss of taste, unwell, headache, cough, flu like symptoms, rhinorrhoea, muscle aches 2 trimester miscarriage. Outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1822537 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-18
Onset:2021-08-22
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-10-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE2707 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101370340

Write-up: Miscarriage; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, regulatory authority number FR-AFSSAPS-PB20216522. This physician reported information for mother. This is a maternal report. A 25-years-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 18Aug2021 (Batch/Lot Number: FE2707) as dose 1, single for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 22Aug2021: occurrence of miscarriage. Patient presented a few days after her Dose 1 vaccination (on Day 4): termination of the pregnancy without specific symptoms requiring her hospitalization for curettage. The mother was 1 Trimester pregnant at the onset of the event. The mother was due to deliver on 23Apr2022. The mother delivered the pregnancy on 22Aug2021. The pregnancy resulted in spontaneous abortion. The fetal outcome is intrauterine death. Outcome of the event was recovered with sequel. No follow-up attempts possible. No further information expected.


VAERS ID: 1875123 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-22
Onset:2021-08-22
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-11-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Diarrhoea, Discharge, Hypoaesthesia, Inappropriate schedule of product administration, Neuralgia, Vaginal haemorrhage
SMQs:, Peripheral neuropathy (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Pseudomembranous colitis (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Termination of pregnancy and risk of abortion (narrow), Noninfectious diarrhoea (narrow), Medication errors (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101507146

Write-up: it started a day after the first vaccine; bleeding; Nerve pain; numbness; smelly discharge; Miscarriage; dose 1 on 25Jun2021 and dose 2 on 22Aug2021; This is a spontaneous report from a contactable consumer. This is a report received from the Agency Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202111021742403460-RNSP1, Safety Report Unique Identifier GB-MHRA-ADR 26151658. A female pregnant patient of an unspecified age received BNT162B2 (COVID-19 MRNA VACCINE BIONTECH, Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration on 22Aug2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. Unsure if patient has had symptoms associated with COVID-19. Not had a COVID-19 test. The patient''s concomitant medications were not reported. Patient previously had COVID-19 MRNA VACCINE BIONTECH on 25Jun2021 for covid-19 immunisation and had severe nerve pain and maternal drug exposure. On 26Aug2021, miscarriage. On an unspecified date, the patient experienced it started a day after the first vaccine (Diarrhoea), bleeding, nerve pain, numbness, smelly discharge. Miscarriage which started with abnormal water and smelly discharge a few days after the vaccine, with numbness and abnormal symptoms preceding it. Bleeding occurred, and the foetus was passed. Severe nerve pain on left side of the body which has progressively spread to the right arm as well. It started a day after the first vaccine, and has flared up more regularly after the second. Patient has not tested positive for COVID-19 since having the vaccine Patient is not enrolled in clinical trial. Outcome of event diarrhoea, bleeding, numbness, Discharge was unknown, nerve pain was not recovered, miscarriage was recovered 01Sep2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1623490 (history)  
Form: Version 2.0  
Age: 33.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-08-22
Onset:2021-08-23
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-08-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 RA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Abortion spontaneous, Menstruation irregular
SMQs:, Termination of pregnancy and risk of abortion (narrow), Fertility disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Early period or miscarriage


VAERS ID: 1676540 (history)  
Form: Version 2.0  
Age: 29.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-23
Onset:2021-08-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3003651 / 2 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Headache, Maternal exposure during pregnancy, Pain
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBMODERNATX, INC.MOD20212

Write-up: This case was initially received via on 24-Aug-2021. The most recent information was received on 31-Aug-2021 and was forwarded to Moderna on 31-Aug-2021. This regulatory authority retrospective pregnancy case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (Pregnancy adverse effects details: Miscarriage) in a 29-year-old female patient who received mRNA-1273 (Moderna CoviD-19 Vaccine) (batch no. 3003651) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included FOLIC ACID for Folic acid supplementation and Folic acid supplementation. On 23-Aug-2021, the patient received second dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) 1 dosage form. The patient''s last menstrual period was on 06-Jul-2021 and the estimated date of delivery was 12-Apr-2022. On 23-Aug-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy), PAIN (Pain) and HEADACHE (Headache). On an unknown date, the patient experienced ABORTION SPONTANEOUS (Pregnancy adverse effects details: Miscarriage) (seriousness criterion medically significant). The patient received mRNA-1273 (Moderna CoviD-19 Vaccine) beginning around the seventh week of the pregnancy. The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 23-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. At the time of the report, ABORTION SPONTANEOUS (Pregnancy adverse effects details: Miscarriage) outcome was unknown and PAIN (Pain) and HEADACHE (Headache) had not resolved. The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Unknown) was unknown. Treatment information is not provided. Patient does think vaccination had an adverse effect on the pregnancy Company Comment: This is a case of product exposure during pregnancy with an associated adverse event of abortion spontaneous, headache and pain in the mother. Based on temporal association a causal relationship cannot be excluded Most recent FOLLOW-UP information incorporated above includes: On 31-Aug-2021: Significant follow-up received on 31-Aug-2021- Pregnancy outcome Miscarriage Dose details were added; Sender''s Comments: This is a case of product exposure during pregnancy with an associated adverse event of abortion spontaneous, headache and pain in the mother. Based on temporal association a causal relationship cannot be excluded


VAERS ID: 1697311 (history)  
Form: Version 2.0  
Age: 40.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-04
Onset:2021-08-23
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-09-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FD7221 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Haemorrhage, Ultrasound scan
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: ultrasound; Result Unstructured Data: Test Result:baby was alive/ could hear the beating; Comments: I performed an ultrasound where I could hear the baby''s heartbeat and the physician said it was fine; Test Date: 20210823; Test Name: ultrasound; Result Unstructured Data: Test Result:the fetus stopped growing at nine weeks; Comments: the fetus stopped growing at nine weeks and was without heartbeat or movement, that is, it was dead, which led to a miscarriage on 24Aug2021
CDC Split Type: BRPFIZER INC202101137051

Write-up: I was 9 weeks pregnant when I took the Pfizer vaccine/ the fetus stopped growing at nine weeks and was without heartbeat or movement, that is, it was dead, which led to a miscarriage on 24Aug2021; bleeding; This is a spontaneous report from a contactable consumer (Patient). This consumer or other non hcp reported information for both mother and fetus/baby. This is a mother report. A 40-years-old Pregnant female patient received first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number: FD7221, Expiry date was not reported), via an unspecified route of administration on 04Aug2021 (at the age of 40-years-old) as single dose for COVID-19 immunization. The patient medical history and concomitant medications was not reported. The Patient is pregnant at the time of vaccination. On 23Aug2021, the patient experienced, she have come to report that I was 9 weeks pregnant when she took the Pfizer vaccine. It so happens that, on 23Aug2021, she had an ultrasound, because she started to have bleeding. This examination found that the fetus stopped growing at nine weeks and was without heartbeat or movements, that is, it was dead, which led to a miscarriage on 24Aug2021. Sir, she ask for clarification, as my baby was alive, as at 6 weeks and 5 days of gestation she performed an ultrasound where I could hear the baby''s heartbeat and the physician said it was fine. Patient states she took second dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on 19Oct2021 (at the age of 40-years-old) as single dose for COVID-19 immunization. The outcome for the events was unknown.; Sender''s Comments: Linked Report(s) : BR-PFIZER INC-202101137596 Mother/child


VAERS ID: 1725027 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-06-18
Onset:2021-08-23
   Days after vaccination:66
Submitted: 0000-00-00
Entered: 2021-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC5295 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: LVPFIZER INC202101166769

Write-up: Spontaneous abortion; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB, regulatory authority number is LV-SAM-2021096559. A 37-year-old female patient received BNT162B2 (COMIRNATY), dose 2 intramuscular on 18Jun2021 (Lot Number: FC5295) as dose 2, 0.3 ml single for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced spontaneous abortion on 23Aug2021 10:20. The outcome of the event was unknown. The event was assessed as serious: medically significant. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1738552 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-10
Onset:2021-08-23
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-09-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH J07BX03 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, SARS-CoV-2 test, Ultrasound scan
SMQs:, Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19
Allergies:
Diagnostic Lab Data: Test Date: 20210308; Test Name: SARS-CoV-2 test; Test Result: Positive ; Test Date: 20210823; Test Name: Ultrasound scan; Result Unstructured Data: Test Result:Intrauterine gestational sac with 4 mm..; Comments: ..embryo without cardiac activity; Test Date: 20210906; Test Name: Ultrasound scan; Result Unstructured Data: Test Result:Intrauterine gestational sac with 4 mm ..; Comments: ..craniocaudal length embryo without cardiac activity
CDC Split Type: FRPFIZER INC202101194731

Write-up: Miscarriage; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB. The regulatory authority number is FR-AFSSAPS-PO20214787. A 28-year-old 6-weeks pregnant female patient received BNT162B2 (COMIRNATY; solution for injection; lot number: J07BX03), intramuscularly administered in the left arm on 10Aug2021 (gestation period at exposure was at 4 weeks) as dose 1, 0.3 ml single for COVID-19 immunization. Medical history included COVID-19 from 08Mar2021. The patient''s last menstrual period (LMP) was on 13Jul2021 and became pregnant on 27Jul2021. Her expected due date was supposed to be on 19Apr2022. The patient''s concomitant medications were not reported. On 23Aug2021, the patient experienced miscarriage. Ultrasound on 23Aug2021 showed intrauterine gestational sac with 4 mm embryo without cardiac activity. Ultrasound on 06Sep2021 showed intrauterine gestational sac with 4 mm craniocaudal length embryo without cardiac activity. The outcome of the event was recovered on an unspecified date. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1749115 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-02
Onset:2021-08-23
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-09-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Foetal death
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC202101243865

Write-up: Foetal death; This is a spontaneous report from a contactable other health professional via the Regulatory authority. Regulatory authority report number is 625861. This healthcare professional reported that a 30-year-old female patient received bnt162b2 (COMIRNATY) on 02Aug2021 as single dose for covid-19 vaccine. Medical history and concomitant medications were not reported. The patient experienced Foetal death on 23Aug2021. Onset Time in Days reported as Suspect (21 days). The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1816624 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-23
Submitted: 0000-00-00
Entered: 2021-10-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GRPFIZER INC202101350575

Write-up: Spontaneous abortion; This is a spontaneous report from a contactable consumer (patient) downloaded from the Agency Regulatory Authority-WEB, regulatory authority number GR-GREOF-20218029. This consumer reported information for both mother and baby. This is a maternal/mother report. A 29-year-old pregnant female patient received bnt162b2 (COMIRNATY, lot unknown), intramuscular on an unspecified date in 2021 as dose 2, single for Covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced spontaneous abortion (medically significant) on 23Aug2021 with outcome of recovering. Reporter comments: After the administration of the second dose of the vaccine, I had spontaneous abortion of the 7 - 8 week old foetus. Sender''s comments: Two telephone attempts were made on 05Oct2021 and on 06Oct2021 to contact the reporter which were not positive. No follow up attempts possible. No further information is expected. Lot/batch number was not provided and unable to obtain.; Reporter comments: After the administration of the second dose of the vaccine, I had spontaneous abortion of the 7 - 8 week old foetus.; Sender''s Comments: Linked Report(s) : GR-PFIZER INC-202101373720 mother/ baby cases


VAERS ID: 1696272 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Female  
Location: Oklahoma  
Vaccinated:2021-08-11
Onset:2021-08-24
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-09-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205AZ1A / 1 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Abdominal pain, Abortion spontaneous, Amniocentesis normal, Arthralgia, Blood urea normal, Diarrhoea, Drug screen negative, Exposure during pregnancy, Nausea, Pain in extremity, Premature separation of placenta, SARS-CoV-2 test negative, Vomiting, White blood cell count increased
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow), Arthritis (broad), Noninfectious diarrhoea (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: labetalol HCL 100MG 2 times daily Loperamide 2MG once daily as needed Ondansetron 4MG every 8 hours PRN for nausea Ferrous Gluconate 324MG 3 times daily iron supplement
Current Illness: Prenatal Hypertension
Preexisting Conditions: previous history of spontaneous miscarriage
Allergies: Codeine causing rash
Diagnostic Lab Data: Amniocentesis performed due to FOB family history of hemifacial microsomia on 8/10 prior to vaccine date. 8/16 Down''s screening negative, but elevated WBCs (16.28) on this date and urea nitrogen normal 8/19 clear urine sample but WBCs 17.92, COVID test performed and resulted negative, drug screen cleared and negative
CDC Split Type:

Write-up: Vaccine received after recommended by perinatal specialist on 8/11/2021 at the Pharmacy, Normal ultrasound 8/12/2021 8/19/2021 patient developed nausea/vomiting/diarrhea 8/24/2021 patient presents with severe abdominal pain running from hips to center of abdomen and down legs. She is seen and discharged. Patient then presents to the facility and diagnosed with small abruption at 22 weeks. On 8/26 she spontaneously delivers at 22 weeks. Infant was peri-viable and intubation was attempted but ultimately did not survive


VAERS ID: 1700429 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Female  
Location: South Carolina  
Vaccinated:2021-08-20
Onset:2021-08-24
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC3182 / 2 LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy, Muscle spasms, Vaginal haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Dystonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Sjogren''s
Allergies: penicillin
Diagnostic Lab Data:
CDC Split Type:

Write-up: 6 weeks pregnant at the time of vaccination. Estimated due date 04/15/2022. 4 days after vaccination bleeding and cramping began and lasted 10 days, resulting in a miscarriage. 2 normal and healthy pregnancies in 2012 and 2014.


VAERS ID: 1750664 (history)  
Form: Version 2.0  
Age: 34.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-24
Onset:2021-08-24
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abdominal pain, Abortion spontaneous, Fatigue, Maternal exposure during pregnancy, Myalgia, Pain in extremity, Pyrexia
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FIMODERNATX, INC.MOD20213

Write-up: Vaccine exposure during pregnancy; Miscarriage; Abdominal pain; Pain in arm; Exhaustion; Myalgia; Pyrexia; This case was received via Regulatory Agency (Reference number: FI-FIMEA-20214750) on 22-Sep-2021 and was forwarded to Moderna on 22-Sep-2021. This regulatory authority retrospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), ABORTION SPONTANEOUS (Miscarriage), ABDOMINAL PAIN (Abdominal pain), PAIN IN EXTREMITY (Pain in arm), FATIGUE (Exhaustion), MYALGIA (Myalgia) and PYREXIA (Pyrexia) in a 34-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. No Medical History information was reported. On 24-Aug-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 24-Aug-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) (seriousness criterion medically significant), ABORTION SPONTANEOUS (Miscarriage) (seriousness criterion medically significant), ABDOMINAL PAIN (Abdominal pain) (seriousness criterion medically significant), PAIN IN EXTREMITY (Pain in arm) (seriousness criterion medically significant), FATIGUE (Exhaustion) (seriousness criterion medically significant), MYALGIA (Myalgia) (seriousness criterion medically significant) and PYREXIA (Pyrexia) (seriousness criterion medically significant). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Spontaneous Abortion NOS. On 24-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. At the time of the report, ABORTION SPONTANEOUS (Miscarriage), ABDOMINAL PAIN (Abdominal pain), PAIN IN EXTREMITY (Pain in arm), FATIGUE (Exhaustion), MYALGIA (Myalgia) and PYREXIA (Pyrexia) was resolving. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. No concomitant and treatment medication were provided This case concerns a 34-year-old pregnant female with no relevant medical history, who experienced the unexpected serious events of maternal exposure during pregnancy, spontaneous abortion, abdominal pain, pain in the extremity, fatigue, myalgia and pyrexia. The event spontaneous abortion occurred on the same day after the first dose of Moderna mRNA-1273 vaccine. The gestational age of pregnancy/LMP was not reported. The rechallenge is not applicable as the events occurred after the first dose. The reporter did not provide the causality assessment. The benefit-risk relationship of mRNA vaccine in not affected by this report.; Sender''s Comments: This case concerns a 34-year-old pregnant female with no relevant medical history, who experienced the unexpected serious events of maternal exposure during pregnancy, spontaneous abortion, abdominal pain, pain in the extremity, fatigue, myalgia and pyrexia. The event spontaneous abortion occurred on the same day after the first dose of Moderna mRNA-1273 vaccine. The gestational age of pregnancy/LMP was not reported. The rechallenge is not applicable as the events occurred after the first dose. The reporter did not provide the causality assessment. The benefit-risk relationship of mRNA vaccine in not affected by this report.


VAERS ID: 1750801 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-06
Onset:2021-08-24
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-09-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101222872

Write-up: Miscarriage; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Agency (RA)-WEB, regulatory authority number FR-AFSSAPS-RN20212760. A 26-years-old female patient received bnt162b2 (COMIRNATY, solution for injection, lot number and expiry date not reported), intramuscular, administered in left arm on 06Aug2021 as dose 2, single for covid-19 immunisation. The patient had no medical history (reported as no previous history), no covid-19 history and no known allergy. The patient was not tested for COVID-19. The patient''s concomitant medications were not reported. At the time of vaccination, the patient was pregnant (1st trimester of pregnancy) (without additional information). On 24Aug2021, 18 days after vaccination, she had a miscarriage. She consulted a doctor. The event was reported as disabling symptoms. The patient recovered with sequelae on 24Aug2021 from the event miscarriage. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1761139 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-24
Submitted: 0000-00-00
Entered: 2021-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC202101243997

Write-up: Abortion spontaneous; This is a spontaneous report from a contactable other health professional via the Regulatory Authority. Regulatory authority report number is 626175. A 30-year-old female patient received BNT162B2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient experienced abortion spontaneous on 24Aug2021. Onset Time in Days- 19 days. Outcome of the event was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1658500 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: New York  
Vaccinated:2021-08-25
Onset:2021-08-25
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC3183 / 1 RA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Exposure during pregnancy, Premature delivery, Premature labour
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: prenatal vitamins Irion supplements
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: None
CDC Split Type: vsafe

Write-up: I went into labor 4 hours after the vaccine. I delivery my child 1:40AM on 8/26/2021. My baby weight 3IBS and 13 ounces. The estimated due was 10/28/2021.


VAERS ID: 1674820 (history)  
Form: Version 2.0  
Age: 34.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-08-09
Onset:2021-08-25
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-09-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC3181 / 1 RA / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy, Human chorionic gonadotropin, Progesterone decreased, Respiratory syncytial virus infection, Ultrasound antenatal screen abnormal
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow), Opportunistic infections (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: prenatal vitamins; progesterone suppository
Current Illness: food poisoning/stomach bug Aug 1-2, 2021; RSV (speculative) Aug 16-19, 2021
Preexisting Conditions: none
Allergies: none known
Diagnostic Lab Data: initial HCG and progesterone low 08/13/2021; miscarriage confirmed at ultrasound 08/27/2021
CDC Split Type:

Write-up: Miscarriage at 8 weeks pregnant (est. due date April 5, 2022)


VAERS ID: 1765332 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Female  
Location: Missouri  
Vaccinated:2021-08-18
Onset:2021-08-25
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-10-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy, Foetal death, Muscle spasms, Pain, Ultrasound scan abnormal
SMQs:, Malignancy related therapeutic and diagnostic procedures (narrow), Dystonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? Yes
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: 2 ultrasound tests on 2 separate visits.
CDC Split Type:

Write-up: Painful cramping a few days after the 2nd shot, followed by miscarriage several days later, confirmed by 2 separate ultrasound doctor''s visits. Baby died around 6 to 7 weeks into pregnancy.


VAERS ID: 1699963 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-25
Submitted: 0000-00-00
Entered: 2021-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC202101139491

Write-up: This is a spontaneous report from a contactable healthcare professional, via the regulatory authority (report number: 610857). A 36-year-old female patient received unknown dose number of BNT162B2 (Comirnaty, batch/lot# and expiration date not reported), route of administration unspecified, therapy date unspecified, single dose, for COVID-19 immunization. The patient''s medical history and concomitant medications not reported. On Aug 25, 2021, patient had spontaneous abortion; with outcome of not recovered. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.


VAERS ID: 1777768 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-03
Onset:2021-08-25
   Days after vaccination:22
Submitted: 0000-00-00
Entered: 2021-10-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNK / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Early miscarriage (7 weeks of gestation); Normal birth
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101273384

Write-up: spontaneous miscarriage (early miscarriage) at 4 weeks gestation; This is a spontaneous report from a contactable consumer (patient) downloaded from the Regulatory Agency (RA)-WEB. The regulatory authority number is FR-AFSSAPS-RN20212785. A 30-year-old pregnant female patient received the first dose of BNT162B2 (COMIRNATY solution for injection; lot number: UNK), via intramuscular on 03Aug2021 (at an unspecified age) at dose 1, single in the left arm for COVID-19 immunisation. Medical history included early miscarriage (7 weeks of gestation) on Dec2018, early miscarriage (7 weeks of gestation) on Apr2019, and full term pregnancy and labour on Jan2020. The patient was pregnant at the time of vaccination. The patient has no long-term treatment. The patient''s history of allergy was not specified. The patient has no history of COVID-19 infection and was not tested for COVID-19. The patient''s concomitant medications were not reported. On 25Aug2021, the patient experienced spontaneous miscarriage (early miscarriage) at 4 weeks gestation. Outcome of the event was reported as recovered on 25Aug2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1796112 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-25
Onset:2021-08-25
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FG4509 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain lower, Abortion spontaneous, Exposure during pregnancy, Myalgia, Pyrexia, Uterine haemorrhage
SMQs:, Rhabdomyolysis/myopathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210825; Test Name: Pyrexia; Result Unstructured Data: Test Result:Not provided
CDC Split Type: FIPFIZER INC202101356272

Write-up: Miscarriage; Uterine haemorrhage; severe lower abdominal pain; Vaccine exposure during pregnancy; Pyrexia; Myalgia; This is a spontaneous report from a contactable consumer (patient) or other non HCP from the Agency Regulatory Authority-WEB, Company number FI-FIMEA-20215336. A 36-years-old pregnant female patient received BNT162B2 (COMIRNATY, formulation: solution for injection, Batch/lot number: FG4509) via intramuscularly on 25Aug2021 as DOSE NUMBER UNKNOWN, SINGLE (at the age of 36 years old) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was pregnant at the time of vaccination. On 25Aug2021 at night first patient experienced severe fever and muscle aches and abdominal pain. On 26Aug2021 in the afternoon began profuse, clear bloody haemorrhage from the uterus. she had a miscarriage. It was reported that until now, the pregnancy had progressed normally. A large bleeding vein was observed in the uterus and the pregnancy no longer progressed. For a week she suffered from severe hard and bleeding until the uterus was emptied medically. Now a month later still severe lower abdominal pain, bleeding vein left in the uterus. It was also reported that patient had to undergo day surgery because of a miscarriage. She had to visit the hospital gynecology outpatient clinic several times. On 27Aug2021 she went for the first time. It was reported that patient was hospitalized due to events. The lab data included body temperature was not provided. At the time of this the outcome of the events were not recovered. No follow-up attempts possible. No further information expected


VAERS ID: 1816609 (history)  
Form: Version 2.0  
Age: 29.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-22
Onset:2021-08-25
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-10-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE3380 / 2 LA / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: FOLIC ACID; PROGESTERONE
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101343306

Write-up: Miscarriage, discovered via scan 3 days post 2nd vaccine; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 29-years-old, via an unspecified route of administration, administered in Arm Left on 22Aug2021 13:00 (Batch/Lot Number: FE3380) as dose 2, single for COVID-19 immunization. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 27Jun2021 13:00 (Batch/Lot Number: EW3143) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication(s) included folic acid and progesterone both taken for an unspecified indication, start and stop date were not reported. The patient experienced miscarriage on 25Aug2021 15:30. The patient was hospitalized for miscarriage, discovered via scan 3 days post 2nd vaccine (abortion spontaneous) for 1 day. The mother reported she became pregnant while taking BNT162B2. The mother was 12 weeks pregnant at the onset of the event. The mother was due to deliver on 10Mar2022. Therapeutic measures were taken: dilation & currette. No other vaccines within 4 weeks prior to the COVID vaccine. The event resulted to a doctor or other healthcare professional office/clinic visit. Prior the vaccination, the patient was not diagnosed with COVID-19 and the patient has not been tested for COVID-19. The outcome of the event was recovered.


VAERS ID: 1823054 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-25
Onset:2021-08-25
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FG3716 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion induced, Abortion missed, Fatigue, Maternal exposure during pregnancy, Ultrasound foetal, Vaccination site irritation
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: OMEGA-3 [OMEGA-3 NOS]; CALCIUM; VITAMIN D [VITAMIN D NOS]; NYCOPLUS MULTI
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Non-smoker; Normal pregnancy
Allergies:
Diagnostic Lab Data: Test Date: 20211004; Test Name: Ultrasound foetal; Result Unstructured Data: Test Result:findings of a missed abortion; Comments: found out that the embryo had a crown-rump length (CRT) of 5-6 mm which suggesting gestation week 6; Test Date: 20211005; Test Name: Ultrasound foetal; Result Unstructured Data: Test Result:missed abortion was verified; Comments: found out that the embryo had a crown-rump length (CRT) of 5-6 mm which suggesting gestation week 6
CDC Split Type: NOPFIZER INC202101370136

Write-up: Missed abortion; local irritation at injection site; tiredness; Medically induced abortion; vaccine vas given in gestation week 5+6; This is a spontaneous report from a non-contactable consumer downloaded from the Regulatory Authority-WEB NO-NOMAADVRE-PASRAPP-2021-U42n8d. This case was received from patient/consumer with the world-wide case reference no. NO-NOMAADVRE-PASRAPP-2021-U42n8d. A 35-year-old pregnant female patient received BNT162B2 (COMIRNATY) (lot number: FG3716), via an unspecified route of administration on the 25Aug2021 14:30 as single dose for COVID-19 immunisation. Medical history included non-smoker and pregnancy. The patient reported having a previous uncomplicated pregnancy. She was healthy, a non-smoker, no allergies, and was not using any medicines regularly. As concomitant medication the patient was given Nycoplus multi tablet, Vitamin D 40 ug, Omega-3 capsule, Calcium 500 mg chewable tablet. The patient developed missed abortion, tiredness, and local irritation at injection site on an unspecified date; medical abortion on 06Oct2021. 04Oct2021: The patient reported that at an ultrasound foetal there were findings of a missed abortion. 05Oct2021: The missed abortion was verified at a gynecological outpatient clinic. 06Oct2021: a medically induced abortion was performed. Based on the ultrasound foetal performed 04Oct2021 and 05Oct2021, they found out that the embryo had a crown-rump length (CRT) of 5-6 mm suggesting gestation week 6. Dose no. 2 of the vaccine vas given in gestation week 5+6. The patient reported getting other light ADRs such as tiredness and vaccination site irritation. The patient recovered from missed abortion on an unspecified date, while outcome of other events was unknown. Reporter Comment: Contact with healthcare professionals: Physician, Other health care professional. The patient reported sick leave due to the ADRs. The patient reported having a previous uncomplicated pregnancy. She was healthy, a non-smoker, no allergies, and was not using any medicines regularly. 04Oct2021: The patient reports that at an ultrasound foetal there were findings of a missed abortion. 05Oct2021: The missed abortion was verified at a gynecological outpatient clinic. 06Oct2021: A medically induced abortion was performed. Based on the ultrasound foetal performed 04Oct2021 and 05Oct2021 they found out that the embryo had a crown-rump length (CRT) of 5-6 mm which suggesting gestation week 6. Dose no. 2 of the vaccine vas given in gestation week 5+6. The patient reports getting other light ADRs such as tiredness and vaccination site irritation. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1826160 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-25
Onset:2021-08-25
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FG4509 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Haemorrhage in pregnancy, Inappropriate schedule of product administration, Ultrasound antenatal screen
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 2021; Test Name: ultrasound; Result Unstructured Data: Test Result:spontaneous abortion
CDC Split Type: FIPFIZER INC202101379155

Write-up: Miscarriage; bloody haemorrhage; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer (patient) downloaded from the Regulatory Authority-WEB FI-FIMEA-20215418. A 32-year-old female patient received bnt162b2 (COMIRNATY), intramuscular in left arm on 25Aug2021 (Batch/Lot Number: FG4509) (at the age of 32 years old) as dose 2, single for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient previously received Comirnaty dose 1 for COVID-19 immunisation. There was an inappropriate schedule of vaccine administered on 25Aug2021. The patient experienced miscarriage on 31Aug2021. The mother reported she became pregnant while taking bnt162b2. The pregnancy resulted in spontaneous abortion. The patient was pregnant 6-7 gestation week when she received the second vaccination. On 31Aug2021, the patient began a bloody haemorrhage and on 08Sep2021 the pregnancy was diagnosed as terminated according to the gynecologist after the ultrasound. The patient underwent lab tests and procedures which included ultrasound: spontaneous abortion (terminated) on unspecified date in 2021. The outcome of the events was recovered on unspecified date. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1874770 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-25
Onset:2021-08-25
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-11-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FF2834 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Abortion spontaneous, Myalgia, Nausea, Pain in extremity, Vaginal haemorrhage
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Termination of pregnancy and risk of abortion (narrow), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Phlebitis; TOP
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101501580

Write-up: miscarried; vaginal bleeding; muscle pains (in the neck, and legs); abdominal cramps; nausea; severe pain in the injected arm; This is a spontaneous report from a contactable consumer or other non HCP downloaded from The regulatory authority report number FR-AFSSAPS-LY202110517. This case consumer or other non HCP reported two doses after BNT162B2. This is the first of two reports for second dose. A 32-year-old female patient received BNT162B2 (COMIRNATY), at the age of 32 years old, dose 2 via intramuscular in left arm on 25Aug2021 (Lot Number: FF2834) as single dose for COVID-19 immunisation. Patient did not have COVID and no test performed. Medical history included termination of pregnancy (TOP), phlebitis. Patient had 2 pregnancies, 0 deliveries (G2P0). Voluntary abortion of the first pregnancy. Patient experienced phlebitis in the days following the abortion and resumption of oral contraception. Patient had no notable family obstetrical history. Her occupation involving a lot of travel. Treatment was none, oral contraception stopped in Apr2021. The patient was pregnant (spontaneous, wanted) at time of vaccination. Date of last menstrual period (LMP) was 15Jun2021 (mid-Jun2021). Good progress of the first 2 months. The patient''s concomitant medications were not reported. The patient previously received BNT162B2, dose 1 in Jul2021 (Lot Number: unknown) as single dose for COVID-19 immunisation and had good tolerance except for mild pain at injection site. On 25Aug2021, second dose of BNT162B2 vaccine was received. That evening and the next day, severe pain in the injected arm. On 27Aug2021, slight improvement of the pain in the arm but appearance of muscle pains (in the neck, and legs). The patient also reported abdominal cramps and nausea. On 28Aug2021, patient experienced vaginal bleeding. Blood loss at 2 months pregnant. On 29Aug2021, patient miscarried. Patient was gradually recovering, she had not sought medical attention, she stated that those around her were supportive. The couple was considering a future pregnancy. Outcome of event miscarried was recovered with sequelae. Outcome of other events was recovering. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-202101508392 same patient, reporter, two doses of vaccine, different events


VAERS ID: 1637625 (history)  
Form: Version 2.0  
Age: 33.0  
Sex: Female  
Location: California  
Vaccinated:2021-02-22
Onset:2021-08-26
   Days after vaccination:185
Submitted: 0000-00-00
Entered: 2021-08-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 062LT20A / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy, Haemorrhage, Human chorionic gonadotropin decreased, Pregnancy test
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Fertility disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Birth Control stopped near second dose.
Current Illness: N/A
Preexisting Conditions: N/A
Allergies: N/A
Diagnostic Lab Data: Pregnancy Test, ER 04/26/2021
CDC Split Type: vsafe

Write-up: About eight weeks after the second dose of the vaccine I had a miscarriage. I had some breakthrough bleeding and I called my doctor. I had an HCG test and the levels were very low. I miscarried after that and the baby was not as far along as I should have been. My HCG levels indicated 1-3 weeks and I should have been 7-8 weeks. Due Date Unknown Pregnancy 4


VAERS ID: 1662316 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2021-08-25
Onset:2021-08-26
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-09-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy, Haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? Yes
Birth Defect? Yes
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Prenatal vitamins, Vitamin D and Levothyroxine
Current Illness: NO
Preexisting Conditions: no
Allergies: NO
Diagnostic Lab Data: NO
CDC Split Type:

Write-up: Only able to get pregnant through IVF/FET. I received the vaccine at 11 weeks pregnant. And the next day I was bleeding and miscarried.


VAERS ID: 1707998 (history)  
Form: Version 2.0  
Age: 39.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-08-14
Onset:2021-08-26
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-09-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC3181 / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Systemic: miscarriage-Severe


VAERS ID: 1786347 (history)  
Form: Version 2.0  
Age: 25.0  
Sex: Female  
Location: Guam  
Vaccinated:2021-03-23
Onset:2021-08-26
   Days after vaccination:156
Submitted: 0000-00-00
Entered: 2021-10-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6204 / 1 LA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8729 / 2 RA / IM

Administered by: Public       Purchased by: ?
Symptoms: Abortion spontaneous, Emotional distress, First trimester pregnancy, Pregnancy test negative, Ultrasound antenatal screen abnormal, Vaginal haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Depression (excl suicide and self injury) (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Allergies: NONE
Diagnostic Lab Data: FIRST TRIMESTER MISCARRIAGE CONFIRMED POST VACCINE BY ULTRASOUND AND BETA HCG Patient is recovering from physical and emotional trauma. Will continue to follow.
CDC Split Type:

Write-up: LMP 7/13/2021 patient states vaginal spotting with blood clots consistent with miscarriage starting 8/26/2021 confirmed post vaccine first trimester miscarriage by ultrasound by beta hcg


VAERS ID: 1803544 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: Maryland  
Vaccinated:2021-08-26
Onset:2021-08-26
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 053E21A / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Dyspnoea, Foetal death, Haemorrhage, Heart rate increased, Hemianaesthesia, Maternal exposure during pregnancy, Transfusion, Uterine dilation and curettage, Vaccination site erythema
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Surgery (she had to have 2 more surgeries)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20213

Write-up: Her unborn baby''s heartbeat stopped; Heartbeat went through the roof - from 140 to 180; She was panting; Had to get an emergency DNC; She was bleeding out/She lost a lot of blood; Had to get a blood transfusion; Whole left arm turned red; Left side of her body became numb; maternal exposure during pregnancy; This spontaneous retrospective pregnancy case was reported by a pharmacist and describes the occurrence of FOETAL DEATH (Her unborn baby''s heartbeat stopped), HEART RATE INCREASED (Heartbeat went through the roof - from 140 to 180), DYSPNOEA (She was panting), HEMIANAESTHESIA (Left side of her body became numb), UTERINE DILATION AND CURETTAGE (Had to get an emergency DNC), HAEMORRHAGE (She was bleeding out/She lost a lot of blood) and TRANSFUSION (Had to get a blood transfusion) in a 31-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Surgery (she had to have 2 more surgeries). On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 26-Aug-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy). On 09-Sep-2021, the patient experienced FOETAL DEATH (Her unborn baby''s heartbeat stopped) (seriousness criteria hospitalization and medically significant), HEART RATE INCREASED (Heartbeat went through the roof - from 140 to 180) (seriousness criterion hospitalization), DYSPNOEA (She was panting) (seriousness criterion hospitalization), UTERINE DILATION AND CURETTAGE (Had to get an emergency DNC) (seriousness criterion hospitalization), HAEMORRHAGE (She was bleeding out/She lost a lot of blood) (seriousness criteria hospitalization and medically significant) and TRANSFUSION (Had to get a blood transfusion) (seriousness criterion hospitalization). On an unknown date, the patient experienced HEMIANAESTHESIA (Left side of her body became numb) (seriousness criterion medically significant) and VACCINATION SITE ERYTHEMA (Whole left arm turned red). The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. The patient was treated with Surgery for Uterine dilation and curettage. On 26-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved. At the time of the report, FOETAL DEATH (Her unborn baby''s heartbeat stopped), HEART RATE INCREASED (Heartbeat went through the roof - from 140 to 180), DYSPNOEA (She was panting), HEMIANAESTHESIA (Left side of her body became numb), UTERINE DILATION AND CURETTAGE (Had to get an emergency DNC), HAEMORRHAGE (She was bleeding out/She lost a lot of blood), TRANSFUSION (Had to get a blood transfusion) and VACCINATION SITE ERYTHEMA (Whole left arm turned red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Patient went to emergency room 09-Sep-2021 the doctors told her the baby''s heartbeat stopped. They performed an emergency DNC. Patient had to get a blood transfusion because she was bleeding out. She stated she lost a lot of blood. Patient further reported that she had to have two more surgeries after the DNC. She first went to hospital 09-Sep-2021 then back again 11-Sep-2021 to 15-Sep-2021 for two more surgeries. Patient has 3 children and the baby she lost would have been the 4th child. Patient also stated she won''t be able to go to work unless she gets the 2nd dose. Treatment medication use was not provided by the reporter Company Comment: This case concerns a 31-year-old female patient with no relevant medical history reported, who experienced the Serious unexpected events of foetal death, uterine dilation and curettage, haemorraghe, transfusion and hemianesthesia (hospitalized and medically significant). The unexpected situation of Maternal exposure during pregnancy was also reported. The patient received the first dose of vaccine at 12 weeks of gestation. Spontaneous abortion occurred approximately 15 days after the first dose of an unknown schedule of Covid-19 vaccine moderna. Rechallenge is unknown since the patient has not received the second dose of the vaccine. The benefit-risk relationship of Moderna Covid 19 vaccine in not affected by this report.; Sender''s Comments: This case concerns a 31-year-old female patient with no relevant medical history reported, who experienced the Serious unexpected events of foetal death, uterine dilation and curettage, haemorraghe, transfusion and hemianesthesia (hospitalized and medically significant). The unexpected situation of Maternal exposure during pregnancy was also reported. The patient received the first dose of vaccine at 12 weeks of gestation. Spontaneous abortion occurred approximately 15 days after the first dose of an unknown schedule of Covid-19 vaccine moderna. Rechallenge is unknown since the patient has not received the second dose of the vaccine. The benefit-risk relationship of Moderna Covid 19 vaccine in not affected by this report.


VAERS ID: 1700980 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-26
Submitted: 0000-00-00
Entered: 2021-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: TWYNSTA
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC202101139776

Write-up: Abortion spontaneous; This is a spontaneous report from a contactable other health professional via the Agency Regulatory Authority. Regulatory authority report number is 612176. A 34-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included amlodipine besilate, telmisartan (TWYNSTA) taken for an unspecified indication, start and stop date were not reported. The patient experienced abortion spontaneous on 26Aug2021 with outcome of recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1705116 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-26
Submitted: 0000-00-00
Entered: 2021-09-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous incomplete
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC202101139857

Write-up: Abortion spontaneous incomplete; This is a spontaneous report from a contactable other health professional via the regulatory authority. Regulatory authority report number is 612550. A 30-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced abortion spontaneous incomplete on 26Aug2021. The outcome of the event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1746873 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-19
Onset:2021-08-26
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-09-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID.
Current Illness: Arthritis; Collagen disorder (I have a condition called Ehlers Danlos Syndrome, which is a low amount of collagen in the body.); Depression; Fibromyalgia.
Preexisting Conditions: Medical History/Concurrent Conditions: Heart murmur; Pregnancy (Patient no longer pregnant at the time of reporting.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBMODERNATX, INC.MOD20213

Write-up: Maternal exposure during pregnancy; High temperature; Miscarriage; This case was received via Regulatory Authority (Reference number: GB-MHRA-ADR 25972265) on 21-Sep-2021 and was forwarded to Moderna on 21-Sep-2021. This regulatory authority retrospective pregnancy case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (Miscarriage) in a 31-year-old female patient who received mRNA-1273 (Moderna CoviD-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Heart murmur and Pregnancy (Patient no longer pregnant at the time of reporting.) on 14-Aug-2021. Concurrent medical conditions included Fibromyalgia, Depression, Arthritis and Collagen disorder (I have a condition called Ehlers Danlos Syndrome, which is a low amount of collagen in the body.). Concomitant products included FOLIC ACID for Folic acid supplementation. On 19-Aug-2021, the patient received second dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 26-Aug-2021, the patient experienced ABORTION SPONTANEOUS (Miscarriage) (seriousness criterion medically significant). On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) and PYREXIA (High temperature). The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. At the time of the report, ABORTION SPONTANEOUS (Miscarriage) and PYREXIA (High temperature) was resolving and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) outcome was unknown. The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Unknown) was unknown. The patient was pregnant on the 14th August 2021, approximately 6 weeks pregnant. She was getting darker positive tests each day the 20th she did another pregnancy test, which was a lighter positive, and then the next day 21st August the pregnancy test she did was completely negative, no 2nd line at all. She did a urine sample for her GP to send to the hospital, which came back negative on the 27th August, which was also the day she started to lose her baby. She miscarried over the weekend which was also her son''s birthday and during the following week.. 2 previous successful pregnancies. Patient was exposed to the medicine in first-trimester 1 12 weeks. No treatment medication were provided. This case concerns a 31-year-old male patient with reported medical history OF Fibromyalgia, Depression, Arthritis and Ehlers Danlos Syndrome who experienced abortion spontaneous 8 days after maternal exposure during pregnancy and pyrexia Unspecified days after second dose of Spikevax. The reporter did not provide causality assessment. Patient experienced AEs after second dose and no information about the first dose is available rechallenge is not applicable as no additional dosing will be given. The benefit-risk relationship of Spikevax in not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 26-Sep-2021: Follow up received on 26th September 2021 included: medical history Ehlers-Danlos syndrome.; Sender''s Comments: This case concerns a 31-year-old male patient with reported medical history OF Fibromyalgia, Depression, Arthritis and Ehlers Danlos Syndrome who experienced abortion spontaneous 8 days after maternal exposure during pregnancy and pyrexia Unspecified days after second dose of Spikevax. The reporter did not provide causality assessment. Patient experienced AEs after second dose and no information about the first dose is available rechallenge is not applicable as no additional dosing will be given. The benefit-risk relationship of Spikevax in not affected by this report.


VAERS ID: 1766430 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-18
Onset:2021-08-26
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-10-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FG4686 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC202101263088

Write-up: Spontaneous abortion detected in the emergency room; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the Regulatory Agency (RA)-WEB, regulatory authority number IT-MINISAL02-788986. A 32-years-old female patient received bnt162b2 (COMIRNATY, solution for injection, Lot Number: FG4686), via intramuscular route of administration, administered in Arm Left on 18Aug2021 15:35 dose 1, 0.3 ml single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 26Aug2021 patient experienced spontaneous abortion detected in the emergency room (abortion spontaneous). The mother was 6 Weeks pregnant at the onset of the event. The pregnancy resulted in spontaneous abortion. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1769413 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-26
Onset:2021-08-26
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FG6273 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Asthenia, SARS-CoV-2 test, Ultrasound scan
SMQs:, Guillain-Barre syndrome (broad), Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cesarean section (2 pregnancies 1 childbirth)
Allergies:
Diagnostic Lab Data: Test Date: 20210825; Test Name: SARS-CoV-2 test; Test Result: Negative ; Test Date: 20210910; Test Name: ultrasound; Result Unstructured Data: Test Result:Non-progressive mono-embryonic intrauterine pregna; Comments: non-progressive mono-embryonic intrauterine pregnancy; Test Date: 20210917; Test Name: ultrasound; Result Unstructured Data: Test Result:Intrauterine pregnancy stopped at about 5 weeks +; Comments: Intrauterine pregnancy stopped at about 5 weeks + 4 days. either around 26Aug2021
CDC Split Type: FRPFIZER INC202101262320

Write-up: intense asthenia; Miscarriage; This is a spontaneous report received from a contactable consumer or other non-HCP downloaded from the Regulatory Agency (RA)-WEB. The regulatory authority report number is FR-AFSSAPS-LY202111266. This consumer reported different events for both doses of Comirnaty for the same patient. This is the first of two reports. A 36-year-old (pregnant) female patient received the second dose of BNT162B2 (COMIRNATY, solution for injection, lot number: FG6273) via an intramuscular route of administration on 26Aug2021 as a dose 2, single for (at the age of 36 year) COVID-19 immunisation. The patient was pregnant at the time of vaccination. The patient medical history include G2 P1 (2 pregnancies 1 childbirth) 1 cesarean section. The patient had no history of Covid. Last menstruation was on 18Jul2021. Concomitant medications were not reported. Historical vaccine include the first dose of BNT162B2 (COMIRNATY, solution for injection, lot number: unknown) via an unspecified route of administration on 27Jul2021 as dose 1, single for COVID-19 immunisation and patient was on first trimester of pregnancy during the first dose. On 28Aug2021, 48 hours post second vaccination, the patient experienced intense asthenia for 72 hours. The patient was pregnant with 4 weeks during the second dose of the COVID 19 vaccine. On 28Aug2021, she was 5 weeks pregnant, undergone Miscarriage on 26Aug2021. Due date for delivery provided was on 24Apr2022. Treatment medication included drug management with (mifepristone) MIFEGYNE and (misoprostol) MISOONE for the event. The patient underwent lab tests and procedures which included follow-up ultrasound: non-progressive mono-embryonic intrauterine pregnancy on 10Sep2021, on 17Sep2021, control ultrasound: Intrauterine pregnancy stopped at about 5 weeks plus 4 days. either around 26Aug2021 and SARS-CoV-2 test negative on 25Aug2021. Outcome of the event asthenia was recovered on an unspecified date in 2021 while for miscarriage was unknown. No follow-up attempts possible. No further information expected.; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-202101269768 same patient, same drug, different AE


VAERS ID: 1778658 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-26
Submitted: 0000-00-00
Entered: 2021-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC202101284290

Write-up: Abortion spontaneous; This is a spontaneous report from a contactable other health professional via the Agency Regulatory Authority. Regulatory authority report number is 630844. A 33-years-old female patient received bnt162b2 (COMIRNATY, solution for injection, Batch/Lot Number: number was not reported), via an unspecified route of administration on an unspecified date in 2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 26Aug2021 the patient experienced abortion spontaneous. The outcome of event recovered on an unspecified date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1799391 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-26
Onset:2021-08-26
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Appendectomy; Cervix uteri cancer
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRMODERNATX, INC.MOD20213

Write-up: Miscarriage; Maternal Exposure during Pregnancy; This case was received via Regulatory Authority (Reference number: FR-AFSSAPS-PB20216471) on 11-Oct-2021 and was forwarded to Moderna on 11-Oct-2021. This regulatory authority retrospective pregnancy case was reported by a pharmacist and describes the occurrence of ABORTION SPONTANEOUS (Miscarriage) in a 31-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Cervix uteri cancer in 2017 and Appendectomy. On 26-Aug-2021, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 26-Aug-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal Exposure during Pregnancy). On 27-Aug-2021, the patient experienced ABORTION SPONTANEOUS (Miscarriage) (seriousness criterion hospitalization prolonged). The patient was hospitalized on 27-Aug-2021 due to ABORTION SPONTANEOUS. The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 26-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal Exposure during Pregnancy) had resolved. At the time of the report, ABORTION SPONTANEOUS (Miscarriage) had resolved. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medication were provided. This case concerns a 31 year old female with relevant medical history of Cervical Cancer, who experienced the unexpected event of Maternal exposure during pregnancy which occurred on the same day of vaccination with the 2nd dose of mRNA-1273 (Spikevax) , age of gestation at the time of the exposure was 5 weeks. . Another unexpected event of Abortion spontaneous occurred the day after the vaccination with the 2nd dose. The Re-challenge for this case is not applicable. The benefit - risk relationship of mRNA-1273 (Spikevax) is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 11-Oct-2021: Translation received on 14-Oct-2021 includes translation for events and drug information. Sender''s Comments: This case concerns a 31 year old female with relevant medical history of Cervical Cancer, who experienced the unexpected event of Maternal exposure during pregnancy which occurred on the same day of vaccination with the 2nd dose of mRNA-1273 (Spikevax), age of gestation at the time of the exposure was 5 weeks. . Another unexpected event of Abortion spontaneous occurred the day after the vaccination with the 2nd dose. The Re-challenge for this case is not applicable. The benefit - risk relationship of mRNA-1273 (Spikevax) is not affected by this report.


VAERS ID: 1835119 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-24
Onset:2021-08-26
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-11-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH J07BX03 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion missed, Pregnancy test, Ultrasound foetal
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Pregnant
Allergies:
Diagnostic Lab Data: Test Date: 20210826; Test Name: Pregnancy test; Test Result: Positive ; Test Date: 202109; Test Name: Ultrasound fetal; Result Unstructured Data: Test Result:The twin embryo had a size corresponding..; Comments: ..to the age of 4 weeks.
CDC Split Type: NOPFIZER INC202101384354

Write-up: Missed abortion; This is a spontaneous report from a non-contactable consumer (patient) downloaded from the Regulatory Agency (RA)-WEB. The regulatory authority number is NO-NOMAADVRE-PASRAPP-2021-Uy92j2. A 35-year-old pregnant female patient received BNT162B2 (COMIRNATY; solution for injection), intramuscularly administered in the left arm on 24Aug2021 08:00 (lot number: J07BX03) as dose 2, single for COVID-19 immunization. Medical history included pregnancy. Concomitant medication included folic acid. On 26Aug2021, the patient experienced missed abortion. The patient reported getting a positive pregnancy test on 26Aug2021. The symptoms disappeared on 27Aug2021. In Sep2021 (1 month after the positive pregnancy test), ultrasound fetal showed the twin embryo had a size corresponding to the age of 4 weeks. The outcome of the event was recovered on 27Aug2021. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1675776 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-08-13
Onset:2021-08-27
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-09-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 RA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy, Human chorionic gonadotropin, Muscle spasms
SMQs:, Dystonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Hcg blood test - 8/30 & 9/2
CDC Split Type:

Write-up: I unknowingly was about 4 weeks pregnant at time of vaccination. About a week later I started cramping badly for about a week before miscarrying.


VAERS ID: 1779605 (history)  
Form: Version 2.0  
Age: 33.0  
Sex: Female  
Location: California  
Vaccinated:2021-04-08
Onset:2021-08-27
   Days after vaccination:141
Submitted: 0000-00-00
Entered: 2021-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808982 / 1 LA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure before pregnancy, Pregnancy test positive, Ultrasound scan abnormal, Vaginal haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Advair, Montelukast, Claritin, Proair inhaler
Current Illness:
Preexisting Conditions: asthma, hay fever
Allergies:
Diagnostic Lab Data: LMP (last missed period) July 1, pregnancy detected July 30 via HCG urine test. Ultrasound on 9/3 should have detected a 9-week old fetus, but instead no cardiac activity detected and fetus measured 8 weeks. Chromosomal testing was not done on pregnancy tissue, but tumor check came back negative
CDC Split Type:

Write-up: Miscarriage (missed abortion) detected via ultrasound on 9/3. D&C procedure carried out on 9/10. Light spotting continued until 10/3.


VAERS ID: 1703585 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-30
Onset:2021-08-27
   Days after vaccination:28
Submitted: 0000-00-00
Entered: 2021-09-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3004672 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Exposure during pregnancy, Foetal death, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESMODERNATX, INC.MOD20213

Write-up: Late fetal death; Drug exposure during pregnancy; Fever; This case was received via regulatory authority (Reference number: ES-AEMPS-988291) on 08-Sep-2021 and was forwarded to Moderna on 08-Sep-2021. This regulatory authority retrospective pregnancy case was reported by a physician and describes the occurrence of FOETAL DEATH (Late fetal death), EXPOSURE DURING PREGNANCY (Drug exposure during pregnancy) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 3005703 and 3004672) for COVID-19 vaccination. No Medical History information was reported. On 30-Jul-2021, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 27-Aug-2021, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 27-Aug-2021, the patient experienced FOETAL DEATH (Late fetal death) (seriousness criteria hospitalization and medically significant), EXPOSURE DURING PREGNANCY (Drug exposure during pregnancy) (seriousness criterion hospitalization) and PYREXIA (Fever) (seriousness criterion hospitalization). The delivery occurred on an unknown date, which was reported as Still birth. For foetus 1, The outcome was reported as Stillbirth NOS. On 27-Aug-2021, FOETAL DEATH (Late fetal death), EXPOSURE DURING PREGNANCY (Drug exposure during pregnancy) and PYREXIA (Fever) had resolved. mRNA-1273 (Spikevax) (Intramuscular) was withdrawn on 30-Jul-2021. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. There was no concomitant medication reported. There was no treatment medication reported. This case concerns a 38-year-old female patient with unknown obstetric and gynecological history who received mRNA-1273 while pregnant (vaccine exposure during pregnancy) and experienced fever and fetal death on the same date of product administration (Last menstrual period and estimated date of delivery were not provided). There is temporal relationship with reported events, and causality cannot be excluded. However, there is not enough details in this case to strongly suggest a relationship of fatal outcome with product use. Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Translated document uploaded on 10-sep-2021 contains translated term for Muerte de feto a t?rmino as Term still birth; Sender''s Comments: This case concerns a 38-year-old female patient with unknown obstetric and gynecological history who received mRNA-1273 while pregnant (vaccine exposure during pregnancy) and experienced fever and fetal death on the same date of product administration (Last menstrual period and estimated date of delivery were not provided). There is temporal relationship with reported events, and causality cannot be excluded. However, there is not enough details in this case to strongly suggest a relationship of fatal outcome with product use.


VAERS ID: 1716615 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-07
Onset:2021-08-27
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-09-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE8235 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101160478

Write-up: Miscarriage; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number FR-AFSSAPS-AN20213507. A 32-year-old pregnant female patient received BNT162B2 (COMIRNATY; Batch/Lot Number: FE8235) dose 1 intramuscularly administered in the left arm on 07Aug2021 as a single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient had no history of COVID-19 and was not at risk of developing a severe form of COVID-19 disease. The patient''s last menstrual period was 12Jun2021. The patient experienced miscarriage on 27Aug2021, reported as arrest of pregnancy development with expulsion of the embryo on 27Aug2021, reported as serious for disability. It was reported the mother became pregnant while taking BNT162B2 and was due to deliver on 24Mar2022. The mother was 9 weeks pregnant at the onset of the event. The outcome of the event was recovered with sequelae on 27Aug2021. A test for COVID-19 via polymerase chain reaction/serology was not performed. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1721289 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-08-27
Submitted: 0000-00-00
Entered: 2021-09-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Foetal death, Maternal exposure during pregnancy, SARS-CoV-2 test
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Maternal vaccine exposure (COVID-19 vaccine exposure during pregnancy week: 20 weken)
Allergies:
Diagnostic Lab Data: Test Date: 20201109; Test Name: corona, bevestigd met test; Test Result: Positive ; Result Unstructured Data: SARS-CoV-2 test positive
CDC Split Type: NLMODERNATX, INC.MOD20213

Write-up: ; This case was received (Reference number: NL-LRB-00677365) on 13-Sep-2021 and was forwarded to Moderna on 13-Sep-2021. This regulatory authority retrospective pregnancy case was reported by a consumer and describes the occurrence of FOETAL DEATH in a 35-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Maternal vaccine exposure (COVID-19 vaccine exposure during pregnancy week: 20 week) and COVID-19 on 09-Nov-2020. On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 27-Aug-2021, the patient experienced FOETAL DEATH (seriousness criterion medically significant). On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY. The delivery occurred on an unknown date, which was reported as Intrauterine death. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. At the time of the report, FOETAL DEATH and MATERNAL EXPOSURE DURING PREGNANCY outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Nov-2020, SARS-CoV-2 test: positive (Positive) SARS-CoV-2 test positive. No concomitant and treatment medications were provided. This is a case of product exposure during pregnancy with associated adverse event of foetal death for this35-year-old female. Very Limited information regarding the event and the timeframe between it and product exposure has been provided at this time and a causal relationship cannot be excluded. Transaltion of the SD has been requested; Sender''s Comments: This is a case of product exposure during pregnancy with associated adverse event of foetal death for this35-year-old female. Very Limited information regarding the event and the timeframe between it and product exposure has been provided at this time and a causal relationship cannot be excluded. Transaltion of the SD has been requested


VAERS ID: 1739522 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-01
Onset:2021-08-27
   Days after vaccination:57
Submitted: 0000-00-00
Entered: 2021-09-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC202101195530

Write-up: Miscarriage at about 7 weeks; This is a spontaneous report from a contactable consumer or other non hcp (patient) downloaded from the Regulatory Authority-WEB NL-LRB-00681317. A 26-years-old female patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 01Jul2021 (Batch/Lot Number: Unknown) as DOSE 1, SINGLE for covid-19 immunisation. Medical history and concomitant medications were not reported. No previous COVID-19 infection. The patient experienced miscarriage at about 7 weeks on 27Aug2021. This was the first Covid vaccination, which took place before pregnancy. The outcome was unknown. Sender Comment: Since the nature of the reported reaction does imply seriousness according to one of the CIOMS critera, the reaction was considered as serious by the Regulatory Authority. Reporter''s comment: BioNTech/Pfizer vaccine (Comirnaty) Past drug therapy BioNTech/Pfizer vaccine (Comirnaty): no. Miscarriage Additional information ADR: On 03Sep, it was announced that I had a miscarriage at about 7 weeks of pregnancy confounding factors COVID-19 vaccine exposure during pregnancy week: 0-1 COVID-19 Previous COVID-19 infection: No Other diagnostic procedures: No No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reporter''s Comments: BioNTech/Pfizer vaccine (Comirnaty) Past drug therapy BioNTech/Pfizer vaccine (Comirnaty): no Miscarriage Additional information ADR: On 03Sep, it was announced that I had a miscarriage at about 7 weeks of pregnancy confounding factors COVID-19 vaccine exposure during pregnancy week: 0-1 COVID-19 Previous COVID-19 infection: No Other diagnostic procedures: No


VAERS ID: 1773345 (history)  
Form: Version 2.0  
Age: 33.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-27
Onset:2021-08-27
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA UNKNOWN / 2 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Adenomyosis, Body temperature, Cystoscopy, Dysmenorrhoea, Foetal death, Haemoglobin, Maternal exposure during pregnancy, Platelet count, Pyrexia, Trisomy 21, Ultrasound scan, White blood cell count
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Congenital, familial and genetic disorders (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: VISANNE; ZOESYN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Endometriosis of uterus (Bladder endometriosis was noted 4 year ago when urine frequency every 30~60 min.); Meningioma
Allergies:
Diagnostic Lab Data: Test Date: 20210827; Test Name: Body temparature; Result Unstructured Data: 38.2 degree Celsius; Test Name: Cystoscopic biopsy; Result Unstructured Data: showed Endometriosis at GCMH; Test Date: 20210923; Test Name: Hb; Result Unstructured Data: Normal; Test Date: 20210923; Test Name: PLT; Result Unstructured Data: Normal; Test Name: Down screening; Result Unstructured Data: low risk; Comments: First trimester Down screening; Test Name: sonography; Result Unstructured Data: Hydrops fetalis with breech presentation at GA18-19 weeks; Test Date: 20210923; Test Name: WBC; Result Unstructured Data: Normal
CDC Split Type: TWMODERNATX, INC.MOD20213

Write-up: Bladder endometriosis; Intraabdominal fetal death; severe dysmenorrhea; She had received 2nd dose of Moderna on 08/27/2021 and fever up to 38.2*C for 1 day; vaccine exposure during pregnancy; This regulatory authority retrospective pregnancy case was reported by a physician and describes the occurrence of FOETAL DEATH (Intraabdominal fetal death) and ADENOMYOSIS (Bladder endometriosis) in a 33-year-old female patient (gravida 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Endometriosis of uterus (Bladder endometriosis was noted 4 year ago when urine frequency every 30~60 min.) and Meningioma. Concomitant products included DIENOGEST (VISANNE) and ETHINYLESTRADIOL, NORETHISTERONE ACETATE (ZOESYN) for an unknown indication. On 27-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 27-Aug-2021, the patient experienced PYREXIA (She had received 2nd dose of Moderna on 08/27/2021 and fever up to 38.2*C for 1 day) and MATERNAL EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). On 15-Sep-2021, the patient experienced FOETAL DEATH (Intraabdominal fetal death) (seriousness criteria hospitalization and medically significant). On 23-Sep-2021, the patient experienced ADENOMYOSIS (Bladder endometriosis) (seriousness criterion hospitalization). On an unknown date, the patient experienced DYSMENORRHOEA (severe dysmenorrhea). The patient was hospitalized on 23-Sep-2021 due to ADENOMYOSIS. The cesarean delivery occurred on 15-Sep-2021, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. Gestation Period- 22+3 weeks. The patient was treated with TOLTERODINE L-TARTRATE (DETRUSITOL SR) ongoing since an unknown date at an unspecified dose and frequency and Surgery (bladder endometriosis removal) for Adenomyosis. On 27-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved. On 28-Aug-2021, PYREXIA (She had received 2nd dose of Moderna on 08/27/2021 and fever up to 38.2*C for 1 day) had resolved. At the time of the report, FOETAL DEATH (Intraabdominal fetal death), ADENOMYOSIS (Bladder endometriosis) and DYSMENORRHOEA (severe dysmenorrhea) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Aug-2021, Body temperature: 38.2 degree celsius (High) 38.2 degree Celsius. On 23-Sep-2021, Haemoglobin: 10.1 (normal) Normal. On 23-Sep-2021, Platelet count: 255k (normal) Normal. On 23-Sep-2021, White blood cell count: 7.04k (normal) Normal. On an unknown date, Cystoscopy: abnormal (abnormal) showed Endometriosis at GCMH. On an unknown date, Trisomy 21: low risk low risk. On an unknown date, Ultrasound scan: abnormal (abnormal) Hydrops fetalis with breech presentation at GA18-19 weeks. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient received regular prenatal examination at OPD. A 2 cm bladder lesion was noted and Cystoscopic biopsy showed endometriosis at CGMH. Overactive bladder was under controlled with Detrusitol SR or Oxbu. This pregnancy was conceived naturally. Preeclampsia screening test revealed low risk. Amniocentesis and aCGH was not performed. SMA and fragile X genetic testing were never performed before. Company Comment: This case concerns a 33-year-old, female patient with a medical history of endometriosis and meningioma, who experienced the unexpected events of maternal exposure during pregnancy, foetal death, adenomyosis and dysmenorrhoea. The event foetal death occurred approximately 19 days after the second dose of Moderna Covid-19 vaccine, Cesarean delivery was done and reported as spontaneous abortion (gestational period 22+3 weeks). Patient was hospitalized again 8 days later due to adenomyosis. The rechallenge was unknown since no information about the first dose was disclosed. The benefit-risk relationship of the vaccine is not affected by this report.; Sender''s Comments: This case concerns a 33-year-old, female patient with a medical history of endometriosis and meningioma, who experienced the unexpected events of maternal exposure during pregnancy, foetal death, adenomyosis and dysmenorrhoea. The event foetal death occurred approximately 19 days after the second dose of Moderna Covid-19 vaccine, Cesarean delivery was done and reported as spontaneous abortion (gestational period 22+3 weeks). Patient was hospitalized again 8 days later due to adenomyosis. The rechallenge was unknown since no information about the first dose was disclosed. The benefit-risk relationship of the vaccine is not affected by this report.


VAERS ID: 1784203 (history)  
Form: Version 2.0  
Age: 25.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-15
Onset:2021-08-27
   Days after vaccination:165
Submitted: 0000-00-00
Entered: 2021-10-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2163 / 2 LA / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, SARS-CoV-2 test
SMQs:, Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: SARS-CoV-2 test; Result Unstructured Data: Test Result:Unknown results
CDC Split Type: JPPFIZER INC202101146280

Write-up: Abortion spontaneous; This is a report from a Non-Interventional Study source. A 25-year-old female subject received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration, administered in Left upper arm on 22Feb2021 (Lot Number: EP2163; Expiration Date: 31May2021) (at the age of 25-year-old) as single dose and dose 2 via an unspecified route of administration, administered in Left upper arm on 15Mar2021 (Lot Number: EP2163; Expiration Date: 31May2021) (at the age of 25-year-old) as single dose for covid-19 immunisation. Medical history including family history was not reported. The subject did not receive any concomitant medication. The subject had no presence or absence of complication (vaccination coupons); no presence or absence of allergy; no presence or absence of complication (medical questionnaire); no presence or absence of medical history; no presence or absence of treatment drug which the subject is orally taking; no suspected pregnancy, presence or absence of breastfeeding. On unknown date (unknown days after the second vaccination), the subject got pregnant. The subject was pregnant during observation period. The subject was not breastfeeding during observation period. Serious adverse event occurred. On 27Aug2021, the subject experienced abortion spontaneous. Severity was moderate. The subject received treatment for the event. On 27Aug2021, the outcome of the event was recovered. Causality was assessed as related to BNT162b2. The subject did not receive any other vaccinations. SARS-CoV-2 test was performed. The subject did not have COVID-19. The outcome of the event was recovered on 27Aug2021. Follow-up (27Sep2021): This is a report from a Non-Interventional Source for Protocol C4591006 from the same physician, an investigator of the study. New information reported includes follows: new event (abortion spontaneous), case upgraded as serious.; Sender''s Comments: Based on the information available and close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events . The case will be reassessed once new information is available The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 1786892 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-02
Onset:2021-08-27
   Days after vaccination:25
Submitted: 0000-00-00
Entered: 2021-10-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC202101323262

Write-up: vaccine exposure during pregnancy week: 4; Miscarriage at about 7.5 weeks; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the Regulatory Agency (RA)-WEB NL-LRB-00690004. A 32-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on 02Aug2021 as a single dose for COVID-19 immunisation. The patient''s medical history included maternal vaccine exposure on an unspecified date. The patient''s concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: unknown) via an unspecified route of administration on 26Jun2021 for covid-19 immunization and no adverse events reported. On 27Aug2021 the patient experienced Miscarriage. On an unspecified date the patient experienced vaccine exposure during pregnancy. The reporter reported miscarriage occurred at a pregnancy duration of about 7,5 weeks. The second Covid vaccination took place at a pregnancy duration of about 4 weeks. The first Covid vaccination took place before pregnancy. The patient was not pregnant at the time of first dose of vaccination on 26Jun2021. Reporter reported vaccine exposure during pregnancy week: 4 and Stop date for event miscarriage reported as 27Aug2021. The outcome of the events miscarriage and maternal exposure during pregnancy was unknown. No follow-up attempts are possible, information on batch number cannot be obtained.


VAERS ID: 1817486 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-27
Onset:2021-08-27
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion induced, Cervical incompetence, Gynaecological examination, Maternal exposure during pregnancy, Premature labour, Premature rupture of membranes, Vital signs measurement
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Tocolysis (September 1 Admitted to our DR for tocolysis initially due to triplet pregnancy at 21+3 weeks with preterm labor and premature rupture of membrane)
Allergies:
Diagnostic Lab Data: Test Date: 20210830; Test Name: Pelvic examination; Result Unstructured Data: showed partially delivered at vagina; Test Date: 20210830; Test Name: Speculum examination; Result Unstructured Data: Speculum exam was done and no preterm premature rupture of membrane was told, but cervical length was not measured; Comments: Normal; Test Date: 20210903; Test Name: VITAL SIGNS; Result Unstructured Data: stable
CDC Split Type: TWMODERNATX, INC.MOD20213

Write-up: bulging mass at vagina like a water balloon; The patient was aborted on September 1, 2021; preterm labor; premature rupture of membrane; Maternal exposure during pregnancy; This regulatory authority retrospective pregnancy case was reported by a pharmacist and describes the occurrence of PREMATURE LABOUR (preterm labor), PREMATURE RUPTURE OF MEMBRANES (premature rupture of membrane), CERVICAL INCOMPETENCE (bulging mass at vagina like a water balloon) and ABORTION INDUCED in a 31-year-old female patient (gravida 1, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. MEDICAL HISTORY (Parent): September 1 Admitted to our DR for tocolysis initially due to triplet pregnancy at 21+3 weeks with preterm labor and premature rupture of membrane. MEDICAL HISTORY (Patient): The patient''s past medical history included Tocolysis (September 1 Admitted to our DR for tocolysis initially due to triplet pregnancy at 21+3 weeks with preterm labor and premature rupture of membrane) on 01-Sep-2021. On 27-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 27-Aug-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On 01-Sep-2021, the patient experienced PREMATURE LABOUR (preterm labor) (seriousness criterion hospitalization prolonged) and PREMATURE RUPTURE OF MEMBRANES (premature rupture of membrane) (seriousness criteria hospitalization prolonged and medically significant). 01-Sep-2021, the patient experienced ABORTION INDUCED (The patient was aborted on September 1, 2021) (seriousness criteria hospitalization prolonged and medically significant). On 01-Sep-2021 at 4:30 AM, the patient experienced CERVICAL INCOMPETENCE (bulging mass at vagina like a water balloon) (seriousness criterion hospitalization prolonged). The patient was hospitalized from 01-Sep-2021 to 03-Sep-2021 due to ABORTION INDUCED, CERVICAL INCOMPETENCE, PREMATURE LABOUR and PREMATURE RUPTURE OF MEMBRANES. The patient gave birth to 1 neonate. For neonate 1, the vaginal delivery which was reported as Premature. The outcome was reported as Pre-Term Birth NOS. fetus was alive with limb movements 21 weeks and 3 days gestation period. For foetus 2, the vaginal delivery which was reported as Elective Termination. The outcome was reported as Elective Termination NOS. fetus B with head at cervix and fetal heart beat was in normal range and with moderate variability. 21 weeks and 3 days gestation period. For foetus 3, the vaginal delivery which was reported as Elective Termination. The outcome was reported as Elective Termination NOS. fetus C was with fetal heart beat in normal range and with moderate variability. 21 weeks and 3 days gestation period. The patient was treated with OXYTOCIN on 01-Sep-2021 at an unspecified dose and frequency. On 27-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. On 01-Sep-2021, PREMATURE RUPTURE OF MEMBRANES (premature rupture of membrane) and ABORTION INDUCED had resolved. At the time of the report, PREMATURE LABOUR (preterm labor) and CERVICAL INCOMPETENCE (bulging mass at vagina like a water balloon) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Aug-2021, Gynaecological examination: showed partially delivered at vagina (abnormal) showed partially delivered at vagina and Speculum exam was done and no preterm premature rupture of membrane was told, but cervical length was not measured. On 03-Sep-2021, Vital signs measurement: stable (normal) stable. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided by the reporter. On 01-SEP-2021 patient underwent sonography where results were found as fetus B with head at cervix and fetal heart beat was in normal range and with moderate variability; and fetus C was with fetal heart beat in normal range and with moderate variability. Patient age at the time of Onset of Reaction was 31.9 CC:This case concerns a 31-year-old, female patient currently undergoing a 21-week triplet pregnancy, who experienced the unexpected and serious events of premature labor, premature rupture of membranes, cervical incompetence and abortion induced; the unexpected event of maternal exposure during pregnancy was also reported. The events occurred 5 days after a dose of COVID-19 vaccine mRNA was administered. The rechallenge was not applicable since only information of one dose is disclosed. 21-week triplet pregnancy remains as a confounder. The benefit-risk relationship of COVID-19 vaccine mRNA is not affected by this report. Sender''s Comments: This case concerns a 31-year-old, female patient currently undergoing a 21-week triplet pregnancy, who experienced the unexpected and serious events of premature labor, premature rupture of membranes, cervical incompetence and abortion induced; the unexpected event of maternal exposure during pregnancy was also reported. The events occurred 5 days after a dose of COVID-19 vaccine mRNA was administered. The rechallenge was not applicable since only information of one dose is disclosed. 21-week triplet pregnancy remains as a confounder. The benefit-risk relationship of COVID-19 vaccine mRNA is not affected by this report.


VAERS ID: 1819037 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-17
Onset:2021-08-27
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-10-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Ultrasound foetal
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210823; Test Name: structural ultrasound; Result Unstructured Data: Test Result:everything was found to be ok; Comments: everything was found to be ok
CDC Split Type: FIPFIZER INC202101356279

Write-up: Late miscarriage; This is a contactable physician from contactable consumer (patient) downloaded from a regulatory authority-WEB. This is a report received from a regulatory authority. Regulatory authority report number FI-FIMEA-20215274. A 28-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in Arm Left on 17Aug2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The mother reported she pregnant while taking bnt162b2. The mother was 19 Weeks pregnant at the time of exposure. The mother was 20 Weeks pregnant at the onset of the event. The mother was pregnant with 1 baby. The mother delivered the pregnancy on 27Aug2021. The pregnancy resulted in spontaneous abortion, fetus died: late miscarriage on 27Aug2021. It was reported that the patient experienced late miscarriage on 27Aug2021. The clinical course was reported by the patient as follows: The first part of the coronary vaccine. The patient could not say whether there was an effect, but she was pregnant in weeks 19-20 and about a week after the vaccination her pregnancy ended for a hitherto unexplained reason. They had just gone to structural ultrasound on 23Aug2021, where everything was found to be ok. They went on a summer vacation trip the same day. She had a strange white leak, clumpy, no blood, no pain, no other. On Tuesday, 24Aug2021, they stopped for a gynecologist check, in which it was found that childbirth had just begun: the uterus was open, and the fetal sac was visible. They stayed for five days in a hospital where an attempt was made to continue the pregnancy without success. The miscarriage of middle pregnancy finally occurred on day 27Aug2021 in pregnancy week 20 + 6. No inflammation was found in her and no other explanatory cause has been found in her or the fetus. The baby was energetic until the end, and there were no visible structural abnormalities in him and the placenta. The patient stated, "I do not know if there is any reason for this, but I really hope that you investigate whether there have been more miscarriages after covid vaccinations were given. I know that the investigation takes time and it is up to the notifier to decide whether the things revealed. I am just so bitter to life with all this and inevitably looking for reasons for what happened. I would not have wanted to take the vaccine while I was pregnant, but then health care was giving such strong recommendations that I dared. And in just over a week, I was no longer pregnant. Of course, the question arises as to whether this devil vaccine has anything to do with it." Outcome of the event was recovered with sequelae on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1798943 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-07-09
Onset:2021-08-28
   Days after vaccination:50
Submitted: 0000-00-00
Entered: 2021-10-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FA9091 / 2 LA / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Miscarriage at week 5.


VAERS ID: 1703183 (history)  
Form: Version 2.0  
Age: 39.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-17
Onset:2021-08-28
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-09-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEPFIZER INC202101129159

Write-up: Got a miscarriage on August 28, probably at week 9 or 10,; This is a spontaneous report from a non-contactable pharmacist reporting about herself. A 39-year-old pregnant female patient received BNT162b2 (COMIRNATY, lot number: UNKNOWN), dose 2 via an unspecified route of administration, administered in left arm on 17Aug2021 (at the age of 39 years) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Past drug included BNT162b2 (COMIRNATY, lot number: UNKNOWN), dose 1, unspecified route of administration and date as a single dose for COVID-19 immunization. The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The mother reported she became pregnant while taking BNT162b2. Patient was pregnant at time of vaccination. Last menstrual date was 20Jun2021 (estimated deliver on 27Mar2022). The patient experienced a miscarriage on 28Aug2021, probably at week 9 or 10 (serious) on 28Aug2021. The patient received no treatment for the event. The outcome of miscarriage was unknown. No follow-up attempts are possible, information on lot number cannot be obtained.; Sender''s Comments: A contributory role of BNT162B2 to the event miscarriage cannot be fully excluded based on temporal relationship. However, currently available information is limited. This case will be reassessed when follow-up received. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 1721299 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-11
Onset:2021-08-28
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-09-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NOPFIZER INC202101155591

Write-up: MISCARRIAGE; This is a spontaneous report from a non-contactable consumer or other non-healthcare professional (non-HCP) downloaded from the regulatory authority-WEB, regulatory authority number NO-NOMAADVRE-PASRAPP-2021-U3m242. This consumer or other non-HCP reported information for both mother and fetus/baby. This is the maternal report. A 34-year-old pregnant female patient received the first dose of BNT162B2 (COMIRNATY; solution for injection; Lot Number: Unknown) intramuscularly on 11Aug2021 as a single dose in the left arm for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 28Aug2021 the patient experienced miscarriage, serious for important medical event. The mother reported that she became pregnant while taking BNT162B2. The patient stated that she had three children from before, and she never miscarried before. The reporter stated that the patient developed miscarriage due to the vaccination. There was no more information available regarding this case. The clinical outcome of the event miscarriage was recovered/resolved on an unspecified date. Reporter''s comment: The patient reported "Yes" under "Is reaction still ongoing?" for side effect MISCARRIAGE, but also Recovered/resolved under Outcome. The patient reported to have three children from before, and to never miscarried before. Sender''s comment The case was upgraded from non-serious to serious ("Other Serious (Important Medical Events)"). No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.; Reporter''s Comments: The patient reported "Yes" under "Is reaction still ongoing?" for side effect MISCARRIAGE, but also Recovered/resolved under Outcome. The patient reported to have three children from before, and to never miscarried before.


VAERS ID: 1730845 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-28
Onset:2021-08-28
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3003651 / 2 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy, SARS-CoV-2 test, Scan
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-08-30
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Pregnancy (Patient no longer pregnant at the time of reporting.)
Allergies:
Diagnostic Lab Data: Test Date: 20200320; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Yes - Positive COVID-19 test; Test Name: scan; Result Unstructured Data: 12 week scan and harmony test perfect
CDC Split Type: GBMODERNATX, INC.MOD20213

Write-up: Miscarriage; Maternal exposure during pregnancy; This case was received via Regulatory Authority (Reference number: GB-MHRA-ADR 25951341) on 17-Sep-2021 and was forwarded to Moderna on 17-Sep-2021. This regulatory authority retrospective pregnancy case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (Miscarriage) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 38-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna CoviD-19 Vaccine) (batch no. 3003651) for COVID-19 vaccination. The patient''s past medical history included Pregnancy (Patient no longer pregnant at the time of reporting.). Concomitant products included FOLIC ACID for Folic acid supplementation. On 28-Aug-2021, the patient received second dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 28-Aug-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) (seriousness criterion medically significant). On 30-Aug-2021, the patient experienced ABORTION SPONTANEOUS (Miscarriage) (seriousness criteria death, hospitalization and medically significant). The event occurred on 30-Aug-2021, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 28-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. The patient died on 30-Aug-2021. It is unknown if an autopsy was performed. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2020, SARS-CoV-2 test: yes - positive covid-19 test (Positive) Yes - Positive COVID-19 test. On an unknown date, Scan: 12 week scan and harmony test perfect (normal) 12 week scan and harmony test perfect. The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Unknown) was unknown. The report stated that the patient is perfectly healthy and fit. Perfect obstetric history with two live babies born naturally, with no previous miscarriages. The patient had two previous perfect pregnancies. As she was pregnant and had received the first shot already, she waited until the end of the first trimester, and until the healthy 12-week scan and harmony test before having the second shot. The report stated that the baby died within 48 hours of the second shot. Surgical management of the miscarriage went okay. Details of scans or investigations showed 12-week scan and harmony test perfect. Samples were sent for cytogenetics testing to rule out chromosomal abnomormalities. Resutls will be available in a number of months. Patient has not had symptoms associated with COVID-19. Patient is not enrolled in clinical trial. This case concerns a 38-year-old, female patient with no relevant medical history, who experienced the unexpected events of vaccine exposure during pregnancy and spontaneous abortion. The patient received the second dose of the Moderna COVID-19 Vaccine at 12 weeks of gestation. Spontaneous abortion occurred 2 days after administration of the second dose of the Moderna COVID-19 Vaccine. The event was considered possibly related to the Moderna COVID-19 Vaccine per the reporter''s assessment. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.; Sender''s Comments: This case concerns a 38-year-old, female patient with no relevant medical history, who experienced the unexpected events of vaccine exposure during pregnancy and spontaneous abortion. The patient received the second dose of the Moderna COVID-19 Vaccine at 12 weeks of gestation. Spontaneous abortion occurred 2 days after administration of the second dose of the Moderna COVID-19 Vaccine. The event was considered possibly related to the Moderna COVID-19 Vaccine per the reporter''s assessment. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.


VAERS ID: 1760040 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-16
Onset:2021-08-28
   Days after vaccination:43
Submitted: 0000-00-00
Entered: 2021-10-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Gestational diabetes; Pregnancy in habitual aborter (2 pregnancies stopped); Vaginal delivery (2 vaginal birth)
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101239499

Write-up: Miscarriage; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB FR-AFSSAPS-PA20211716. A 44-year-old pregnant female patient received the first dose of bnt162b2 (COMIRNATY), via intramuscular in the arm left on 16Jul2021 as DOSE 1, 0.3 ML SINGLE for COVID-19 immunisation. Medical history included pregnancy in habitual aborter (2 pregnancies stopped); 2 vaginal birth; notion of gestational diabetes during the last pregnancy found in the Obstetrics report. Concomitant medications were not provided. On 28Aug2021, the patient experienced miscarriage (medically significant) with gestation period was 8 weeks. The patient''s date of last menstrual period was 01Jul2021 and she was at 2 weeks of gestation when she took the vaccine. The patient was due to deliver on 07Apr2022. The fetal outcome was intrauterine death. Outcome of the event was resolved with sequel on unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1783511 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-12
Onset:2021-08-28
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FF4213 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Fatigue, Menstrual disorder, Sleep disorder
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Amenorrhea; Anemia
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202101313972

Write-up: Miscarriage; Sleep disorders; fatigue; important disturbance of the menstrual cycle; This is a spontaneous report from a contactable consumer or other non HCP downloaded from the Regulatory Authority-WEB. The regulatory authority report number FR-AFSSAPS-LL20216311. A 33-years-old female patient received bnt162b2 (COMIRNATY, Formulation: solution for injection, Batch/Lot Number: FF4213) via intramuscular, administered in Arm Left on 12Aug2021 as dose 1, single for COVID-19 immunisation. Medical history included anaemia from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. On 28Aug2021, patient experienced appearance of an important disturbance of the menstrual cycle Miscarriage 16 days after the first injection, at 6 (weeks of amenorrhea), Sleep disorders, Fatigue. Patient has no covid and not been tested. Outcome of the events was recovering. Note as given Imputability without prejudice to the elements of investigation which could be carried out within the framework of legal or amicable procedures of compensation. No follow-up attempts possible. No further information expected.


VAERS ID: 1809763 (history)  
Form: Version 2.0  
Age: 43.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-28
Onset:2021-08-28
   Days after vaccination:31
Submitted: 0000-00-00
Entered: 2021-10-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Abortion, Maternal exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITMODERNATX, INC.MOD20213

Write-up: Spontaneous abortion. Detected by gynecologist; gestational sac was empty at the 8th week of pregnancy.; Maternal exposure during pregnancy; This case was received via regulatory authority (Reference number: IT-MINISAL02-795650) on 14-Oct-2021 and was forwarded to Moderna on 14-Oct-2021. This regulatory authority retrospective pregnancy case was reported by a physician and describes the occurrence of ABORTION (Spontaneous abortion. Detected by gynecologist; gestational sac was empty at the 8th week of pregnancy.) in a 43-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Aug-2021, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 28-Aug-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On 22-Sep-2021, the patient experienced ABORTION (Spontaneous abortion. Detected by gynecologist; gestational sac was empty at the 8th week of pregnancy.) (seriousness criterion medically significant). The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 28-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. At the time of the report, ABORTION (Spontaneous abortion. Detected by gynecologist; gestational sac was empty at the 8th week of pregnancy.) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medication details were provided. On 14-Sep-2021 positive pregnancy test, initial symptoms of pregnancy present breast tenderness, On 22-Sep-2021 Gynecological visit showed finding of empty gestational sac. Company Comment: This case concerns Maternal exposure during pregnancy in a 43 year-old female patient with no reported medical history, who experienced the unexpected serious event of Abortion. The event occurred 26 days after the second dose of mRNA-1273 vaccine. The reported event is spontaneous abortion at 8 weeks of pregnancy based on empty gestational sac identified by Gynecologist. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 14-Oct-2021: Translation received on 14-oct-21 with event reported as primary source updated and reporters and senders comment were updated,; Reporter''s Comments: Additional information was requested from the reporter more than once (batch and other details) but we have not received any replies. 1st dose of Moderna on 28-Jul-2021 [U.M.] 30-Jul-2021, 2nd Moderna dose on 28-Aug-2021, 14-Sep-2021 Positive pregnancy test, initial symptoms of pregnancy present (breast tenderness), 22-Sep-2021 Gynecological visit with finding of empty gestational sac.; Sender''s Comments: This case concerns Maternal exposure during pregnancy in a 43 year-old female patient with no reported medical history, who experienced the unexpected serious event of Abortion. The event occurred 26 days after the second dose of mRNA-1273 vaccine. The reported event is spontaneous abortion at 8 weeks of pregnancy based on empty gestational sac identified by Gynecologist. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=24&PERPAGE=100&ESORT=ONSET-DATE&SYMPTOMS[]=Aborted_pregnancy_%2810000209%29&SYMPTOMS[]=Abortion_%2810000210%29&SYMPTOMS[]=Abortion_complete_%2810061614%29&SYMPTOMS[]=Abortion_early_%2810052846%29&SYMPTOMS[]=Abortion_incomplete_%2810000217%29&SYMPTOMS[]=Abortion_induced_%2810000220%29&SYMPTOMS[]=Abortion_late_%2810052847%29&SYMPTOMS[]=Abortion_missed_%2810000230%29&SYMPTOMS[]=Abortion_of_ectopic_pregnancy_%2810066266%29&SYMPTOMS[]=Abortion_spontaneous_%2810000234%29&SYMPTOMS[]=Abortion_spontaneous_complete_%2810061616%29&SYMPTOMS[]=Abortion_spontaneous_incomplete_%2810061617%29&SYMPTOMS[]=Foetal_cardiac_arrest_%2810084280%29&SYMPTOMS[]=Foetal_death_%2810055690%29&SYMPTOMS[]=Premature_baby_death_%2810076700%29&SYMPTOMS[]=Premature_delivery_%2810036595%29&SYMPTOMS[]=Stillbirth_%2810042062%29&VAX=COVID19


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166